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Abstract 
Obesity is one of the leading cause of death in world’s population, due to the 
comorbidity with pathologies like cardiovascular or mental disorders. Deviating 
from its role as a primary need, obese and overweight people tend to use food as a 
source of pleasure or to relieve from anxiety, typical of addiction to drugs. Thus, 
due to the commonality with drug abuse, like the impulsive-to-compulsive 
progression or the neurotransmitters release, overconsumption of high palatable 
food has been described as a form of addiction. As initially done for fear and drug 
maladaptive memories, food addiction has been investigated with memory 
reconsolidation studies. Reconsolidation theory stated that after stabilization, 
memory can return into a vulnerable state with re-exposure to stimuli previously 
associated to the initial learning and, once reactivated and destabilized, it needs 
reconsolidation to be restabilized. During the vulnerable phase, memory can 
strengthened or disrupted, and memory disruption could prevent relapse. The 
processes of memory destabilization and restabilization have been shown to 
depend on glutamatergic signaling. Moreover, glutamate receptor activity has 
been proposed as modulated by metaplasticity, a novel concept according to 
which neural stimulation could influence future synaptic activity even after 
disappearing of the acute effect. Thus, the goals of the present project was to 
investigate i) whether sucrose instrumental memory can undergo reconsolidation 
and ii) if it is possible to block reconsolidation with the NMDARs antagonist MK-
801 given under a metaplasticity protocol. 
After 10 days of training to sucrose self-administration, rats were fasted for 14 
days and finally treated with vehicle or MK-801 24 hours before retrieval. Then, 
rats were exposed to memory retrieval (Ret) or no-retrieval (No-Ret) and, 24 
hours later, a reinstatement test evaluated sucrose seeking behaviour. Separate 
groups of rats were sacrificed 2 hours after memory Ret/No-Ret for the molecular 
analyses of Zif268, rpS6P and glutamate receptors levels in memory and reward 
key brain areas: nucleus accumbens (NAc) and amygdala (Amy). 
Results showed that sucrose instrumental memory undergo reconsolidation, as 
indicated by the increase of Zif268 and rpS6P in NAc and Amy. These results 
were further supported by the increased level of GluN2B (destabilization marker) 
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and GluA1 (reactivation marker) in Amy, leading us to propose the Zif268/rpS6P 
two-component molecular assay as a valid and reliable method for the assessment 
of instrumental memory reactivation and reconsolidation. Furthermore, we 
demonstrated that the metaplastic treatment with MK-801 significantly decreased 
instrumental responding at the behavioural test only when administrated 24 hours 
before Ret, and this inhibition was associated to a significant decrease of Zif268 
in NAc shell and of rpS6P in central Amy. Moreover, acute MK-801 significantly 
increased GluA1, GluN2B and mGluR5 in NAc and GluN2B in Amy. Here we 
demonstrated that NMDARs blockade affected sucrose instrumental memory, 
hypothesizing that the metaplasticity effect of MK-801 could have induced a 
switch from reconsolidation-to-extinction occurrence. However, it remains to be 
clarified the molecular mechanisms allowing for instrumental responding 
inhibition even at time MK-801 has been completely eliminated, and whether this 
inhibition is long-lasting, making it a possible therapeutic treatment for relapse on 
food addiction. 
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1. INTRODUCTION  
Drug addiction, or substance use disorder as recently redefined in DSM-V, is 
a chronic relapsing disorder characterized by drug seeking and taking 
compulsivity, weak control over drug self-administration, impaired social function 
and emergence of negative emotional state, such as anxiety, dysphoria and/or 
aggressiveness (American Psychiatric Association, 2013; Koob and Le Moal, 
1997). As other chronic diseases, also substance use disorder is characterized by 
susceptibility due to genetic or environmental risk factors, as well as to age, stress, 
physical injury or traumatic emotional experiences (Kendler et al., 2003; 2008). 
The view of addiction as a medical condition provided support for the integration 
of substance use disorder treatments in the healthcare systems, and resulted in the 
development of medicine and clinical trials addressed to find new therapeutic 
strategies for addiction (Volkow et al., 2016). In Europe, in 2015, the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA, 2017) reported that 
23.5 million adults between 15 and 64 years old used cannabis in the last year, 3.5 
million used cocaine, 2.7 million used MDMA and 1.8 million used 
amphetamines. Moreover, Europe has the highest prevalence of tobacco smoking 
(28%) and of alcohol consumption (70%) among adults in the world (WHO, 
2014). 
 
1.1 The neurobiology of addiction 
All drugs of abuse have remarkable effects into the brain, accounting for the 
pleasure and reward feelings usually experienced during the first uses. These 
sensations are those who drive individuals to use substances repeatedly, even in 
the case of negative consequences. The sustained drug intake can in turn induce 
neuroadaptation, the process underlying structural rewiring and neurochemical 
modulation in response to drugs. This pattern of alteration finally results in a self-
sustaining loop that precipitates drug intake from a goal-directed behaviour to a 
compulsive-like habit, strengthening and enhancing the maladaptive condition of 
substance abuse (Everitt and Robbins, 2005). Thus, one of the mail goals of drug 
addiction research is to comprehend the neurobiological mechanisms behind this 
transition and the underlying alteration in brain structures and functions, 
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integrating animal model studies of acute and chronic effects of substances with 
human evidence of drug-induced changes from brain-imaging techniques (Koob 
and Volkow, 2016). 
Information inside the human brain are processed by many different regions 
connecting each other to form dynamic networks responsible for distinct 
functions, such as learning and memory, language, reward, emotions and 
movements. As these functions, also addiction is based on many different brain 
regions; however, it relies mostly on three areas: 
1) prefrontal cortex, located in the most frontal part of the brain;  
2) basal ganglia, i.e. dorsal striatum (or caudate putamen) and ventral 
striatum (or nucleus accumbens), a group of subcortical nuclei located at 
the bases of the forebrain;  
3) amygdala, an almond-shaped group of nuclei located beneath the basal 
ganglia, within the temporal lobes (Fowler et al., 2007). 
These brain regions, and the regulation of reward and emotions, evolved in human 
and other animals to adapt to challenging environment (Figure 1). For example, 
reward motivated individuals to consuming food or having sex, activities 
controlled by the basal ganglia and essential for the survival of the species. 
Instead, the “fight or flight” response controlled by the amygdala evolved to face 
fear or dangerous situations. Prefrontal cortex is the higher order area controlling 
on these low-level, but fundamental, processes. Drugs of abuse take advantage of 
the same survival systems to establish addiction (Saah, 2005).  
Despite being a part of the mesocorticolimbic pathway, prefrontal cortex, 
basal ganglia and amygdala own specific roles involved both in normal life 
situations and in the emerging of addiction: 
1) prefrontal cortex is responsible for the executive functions, complex 
cognitive processes involved in the organization of thoughts and activities, 
decision making, integration of emotional and cognitive information 
(Barbas and García-Cabezas, 2017); 
2) caudate-putamen is involved in more cognitive and motor functions, and it 
has been identified as the core of both goal and habitual-directed 
behaviour (Belin et al., 2009); nucleus accumbens has been suggested as 
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the interface between emotions, motivations and actions due to the inputs 
coming from amygdala, orbitofrontal cortex and hippocampus (Belin et 
al., 2009); 
3) amygdala is involved in the perception of emotions such as fear, anxiety 
and sadness, as well as in the control of aggressiveness. In facts, it is the 
most activated area during abrupt stressing situations, requiring a “fight or 
flight” response. Moreover, amygdala plays a role also in natural 
rewarding activity such as food intake or sexual activity, and in the storage 
of emotionally relevant memories that can be helpful in dealing with 
future similar situations (Adolphs, 2013). 
 
 
Figure 1: The homology between midbrain dopaminergic system in human and 
rats. (Top) The rat dopaminergic (DA) system: the DA neurons affected by 
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addiction are labeled in red, with cell bodies located in the ventral tegmental area 
and innervating the prefrontal cortex (green square), nucleus accumbens and 
caudate-putamen (blue square) and amygdala (red square). (bottom) DA circuitry 
is well conserved in the human brain, with the addiction-affected areas squared as 
on top. (top/bottom) In purple are represented the DA neurons of the substantia 
nigra and involved in other pathologies, like Parkinson’s disease (PD). Taken and 
adapted from Kramer and Liss, 2015.  
 
 
1.2 The addiction cycle  
Drug-taking behaviour progresses from impulsivity to compulsivity (Figure 2) 
following a three-stage cycle, with each stage associated to one of the three main 
areas described above: 
1) binge/intoxication: mostly associated to basal ganglia, it is the stage during 
which people experience the rewarding effects of a substance; 
2) withdrawal/negative affect: mostly associated to amygdala, it is the stage 
during which addicted abstain from the drug, feeling negative emotions 
such as agitation, anxiety and malaise; 
3) preoccupation/anticipation: mostly associated to prefrontal cortex, it is the 
stage during which addicted crave for substance after a period of 
abstinence (Figure 3) (Koob and Le Moal, 1997). 
 
 
Figure 2: The progression from impulsive to compulsive behaviour. After an 
initial episode of arousal or stress, individuals experience an impulsive act 
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providing pleasure or relief. However, the impulsive act could result in a feeling 
of regret after relief, laying the basis for a new episode of stress followed again by 
impulsive act and relief. After a prolonged exposure to this cycle, impulsive acts 
can shift into obsession, generating an anxiety state to which only a repetitive 
behaviour could provide relief. However, relief is only temporary, and individuals 
end eventually in obsession relapse. This sequence underlie the transition from 
response-outcome goal-directed behaviour to the stimulus-response habit-based 
behaviour, typical of addictive disorders. Taken and adapted from Koob, 2011. 
 
 
Figure 3: The three brain regions associated to the three addiction stages. In blue, 
there are the basal ganglia, associated to the first binge/intoxication stage; in red 
the amygdala, linked to the second withdrawal/negative affect stage, and finally, 
in green, the prefrontal cortex, base of the third preoccupation/anticipation stage. 
Taken and adapted from Facing Addiction in America: The Surgeon General's 
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Report on Alcohol, Drugs, and Health (SAMHSA, 2016) and Dr. Levent Efe 
Medical Illustration Studios. 
 
 
1.2.1 Stage 1: binge/intoxication 
The intake of addictive substances produces pleasurable effects and reward 
feelings, which in turn sustain the likelihood of further consumptions. This 
sequence is hypothesized to depend on: i) DA release in the nucleus accumbens 
for psychostimulants such as cocaine, amphetamine and nicotine; ii) on opioid 
receptors activation in accumbens (DA-independent) and in the ventral tegmental 
area (DA-dependent) for opiates and cannabinoids; iii) on GABAergic system 
activation in the nucleus accumbens and amygdala for alcohol (Koob, 2011) 
(Figure 4). Nucleus accumbens, the most important brain area in 
binge/intoxication stage is in a strategic location inside the brain, receiving limbic 
afferents from amygdala, frontal cortex, hippocampus and conveying information 
that can became motivational outputs through extrapyramidal motor cortex (Koob, 
2011). The dorsal part of the basal ganglia, i.e. the dorsal striatum, does not 
appear to contribute to acute reinforcing effects of drug of abuse. Conversely, 
dorsal striatum plays a crucial role in the transition from impulsive to compulsive 
drug use (Everitt et al., 2008).  
Besides drug abused, also stimuli that can be associated to drug intake such as 
people, places and even personal feelings can trigger DA release in the basal 
ganglia and induce craving, seeking and eventually drug taking. This motivational 
appeal induce by non-drug stimuli exposure is called “incentive salience”, and it 
has been demonstrated both in animal models and humans. The association of a 
drug – the unconditioned stimulus, US – to a neutral stimulus such as a light or a 
tone, transfer the reinforcing properties of the drug to the previously neutral 
stimulus, turning it into a conditioned stimulus (CS). The conditioned reinforcing 
properties of stimuli associated with a variety of substances, such as cocaine, 
heroin and even sucrose have been reported to be essential for the persistence of 
addictive behaviour in rats (Di Ciano and Everitt, 2004). In a report of 1997, 
researchers trained naïve monkeys to self-administer fruit juice as US with a 
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concomitant presentation of a light as CS. Surprisingly, after several days of 
training, electrophysiological recording of DA-transmitting neurons activity 
revealed that DA neurons stopped to respond to the US, while continuing to 
respond to the CS. This evidence highlighted the appetitive behavioural reaction 
transfer from the primary stimulus, i.e. the fruit juice, to its associated stimuli 
(Schultz et al., 1997).  
 
 
Figure 4: The common pathways of addictive substances. All drug of abuse, act 
directly or indirectly on nucleus accumbens (NAc) and ventral tegmental area 
(VTA) regions of the brain. 1) Stimulants directly increase DA release in the 
NAc. 2) Opiates act directly on the opioid receptors of NAc, and indirectly on the 
GABAergic interneuron of VTA, inhibiting them and in turn freeing up the 
activity of DA neurons. 3) Nicotine seems to act directly on nicotinic 
acetylcholine receptors (nACh) receptors on DA neurons or indirectly on 
glutamate inputs to DA neurons. 4) Alcohol seems to inhibit GABAergic 
interneurons, disinhibiting DA neurons. 5) Cannabinoids activity appears to 
involve CB1 receptors in the NAc neurons. Finally, 6) PCP and others NMDARs 
blockers like MK-801 or ketamine, antagonize NMDARs in the NAc. Taken and 
adapted from Koob, 2011.  
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1.2.2 Stage 2: withdrawal/negative affects 
After binge/intoxication phase, drug abusers typically experience a period of 
withdrawal, characterized by negative symptoms. These, in turn, provide the basis 
for a future relapse on drug bingeing, considering that, normally, addicted relapse 
on drug taking in order to relieve from negative symptoms (Substance Abuse and 
Mental Health Services Administration, 2016). Symptoms of withdrawal can be 
both emotional, such as anxiety or stress, and physical, such as tremors, nausea 
and even temperature gaps (WHO, 2009). All drugs of abuse can induce 
withdrawal, and the severity of the effects depend on the type of substance, the 
duration and the intake amount. These negative affects are probably related to two 
distinct reasons: the first is the DA depletion caused by damping of reward 
circuitry in basal ganglia, while the second is the activation of the stress system 
based on amygdala.  
In humans, DA depletion in the striatum is evident during withdrawal from 
cocaine (Volkow et al., 2014), nicotine (McLaughlin et al., 2015), alcohol 
(Stobart-Gallagher and Gomez, 2017), opioids (Kosten and George, 2002) and 
abused natural rewards such as food (Parylak et al., 2011) and sex (Kafka, 2010). 
This downregulation of DA system and subsequent reward could underlie, at least 
in part, the compulsive escalation to abuse, in order to obtain the initial pleasure 
sensations by increasing the amount of intake and consequently, increasing DA 
release (Koob and Le Moal, 2001). 
While the striatum regulates reward feelings, the amygdala controls the stress 
system through the activation of stress neurotransmitters like norepinephrine, 
dynorphin and corticotropin-releasing factor (CRF) (Koob and Le Moal, 2008). 
Alcohol addiction and withdrawal, for example, induces a significant increase of 
stress hormones level in plasma and cerebrospinal fluid both in humans (Becker, 
2012) and in rats (Patterson-Buckendahl et al., 2005). Mifepristone, a 
glucocorticoid receptors antagonist, was demonstrated to reduce alcohol self-
administration in alcohol-dependent rats when administrated systemically or 
directly in the central nucleus of amygdala. Moreover, it is effective also in 
humans (Vendruscolo et al., 2015). Furthermore, the blockage of the dynorphin-k 
opioid receptor (KOR) system has been proposed as therapeutic treatment for 
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psychostimulant abuse (Whitfield et al., 2015). Finally, also dysregulated 
endogenous cannabinoid (eCB) signaling seems to contribute to the development 
and maintenance of addictions, including eating disorders, through increased 
stress responsivity and negative emotional states, thus driving to relapse (Parsons 
and Hurd, 2015). 
 
1.2.3 Stage 3: preoccupation/anticipation  
After abstinence, that in heavily abusers can last even few hours, addicts 
frequently begin to feel the need of drug intake again, an event called “craving”. 
Prefrontal cortex, the region controlling executive functions, i.e. the ability to 
organize thoughts and activities, prioritize tasks, manage time and making 
decisions (Koob et al., 2014) as well as to regulate actions, emotions and 
impulses, is the main brain area involved in this phase (Substance Abuse and 
Mental Health Services Administration, 2016). Among the other, decision-making 
and action control are the most compromised functions in addicted behaviour. To 
frame prefrontal cortex activity in a complex scenario like addiction, scientists 
since early ’90 divided this region in two opposed systems: the “GO circuitry” 
and the “STOP circuitry” (Gabriel, 1991).  
The GO circuitry involves anterior cingulate cortex and the dorsolateral 
prefrontal cortex, with the former facilitating maintenance and selection of high 
attention-requiring responses, planning, initiation and monitoring of goal-directed 
behaviour, and the former involved in working memory, planning and strategy of 
actions. Incentive salience-induced drug seeking, based on goal-directed 
behaviour, activates glutamatergic transmission in the prefrontal cortex that in 
turn stimulates nucleus accumbens to release glutamate. Accumbal activation 
promotes incentive salience, creating an excitatory loop contributing to relapse on 
drug taking behaviour. Moreover, the Go circuitry contributes also to impulsive 
behaviours underlying drug seeking and taking through the enrolment of 
glutamatergic habit systems in the dorsal striatum (Koob and Volkow, 2010). 
Furthermore, dysregulation of the Go circuitry can reduced prefrontal cortical 
regulation over negative emotional salience, as reported for cocaine addicted 
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(Crunelle et al., 2015) and patients suffering post-traumatic stress disorder 
(PTSD) (Etkin and Wager, 2007).   
The Stop circuitry instead involves ventrolateral prefrontal cortex and 
orbitofrontal cortex. The former is involved in response inhibition, sustained 
attention and memory reactivation, while the latter regulates the assignment of 
value, as well as the integration of reward and punishment (Koob et al., 2014). 
Stop circuitry counteracts the Go circuitry action on ventral and dorsal striatum, 
thus inhibiting incentive salience and impulsivity-driven drug intake (Substance 
Abuse and Mental Health Services Administration, 2016). In 2007, Volkow and 
colleagues, studying the cortical control over DA release in response to the 
psychostimulant methylphenidate (MP), proposed that the orbitofrontal cortex 
(OFC), part of Stop circuitry, was probably involved in the control of drug 
rewarding properties, and the loss of OFC inhibitory control over compulsivity 
and impulsivity could underlie the escalation toward addiction (Volkow et al., 
2007). Finally, a structural MRI study in 2011 showed that alcoholics possess a 
smaller volume of medial frontal cortex and right lateral prefrontal cortex 
compared to controls, and this reduction was negatively correlated to abstinence 
duration (Rando et al., 2011).  
 
1.3 The addiction disorders 
The definition of addiction disorders refers mainly to two different classes of 
addiction: substance addiction and behavioural non-substance addiction.  
Substance addiction, also called drug addiction, is induce by the 
neurochemical adaptation and circuitry rewiring of the brain in response to the 
intake of a molecule(s) known to possess specific pharmacokinetic and 
pharmacodynamic properties. Typically, the prolonged intake results in a loss of 
control over molecule(s) use, and whose deprivation induces craving and taking 
desire also in spite of physical, social and economic negative consequences.  
Behavioural addiction, instead, covers a plethora of different disorders 
sharing similar adaptation and rewiring effects in brain areas of reward system, 
the same system already demonstrate to be affected by drug addiction, but it 
differs from the latter for the absence of a chemical(s) acting directly or indirectly 
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on the brain. Typical non-substance behavioural addiction comprehend 
pathological gambling, food addiction, internet addiction and mobile phone 
addiction; among them, only gambling disorders has been included in the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-V), highlighting the 
gap still present in the comprehension of behavioural addiction disorders (Zou et 
al., 2017). 
 
1.4 Food addiction 
1.4.1 Excessive food intake and the gut-brain axis 
Obesity, defined as a body mass index (BMI) exceeding 30 kg/m2, is one of 
the leading cause of death in the world’s population, and has reached epidemic 
proportion with at least 2.8 million people dying each year because of being 
overweight or obese. World Health Organization (WHO) estimate that, in 2016, 
1.9 billion adults were overweight and 600 million were obese worldwide, 
respectively the 35% and 11% of world’s population (World Health Organization, 
2017). For the European Union, the healthcare cost for food disorders raise €81 
billion, an expenditure that significantly increase considering all obesity-related 
chronic illnesses (Cuschieri and Mamo, 2016). In fact, excessive adiposity has 
been reported as a key risk factor for the development of many medical conditions 
such as cardiovascular disease, hypertension, type 2 diabetes, strokes and cancer 
(Li et al., 2005), or mental disorders such as major depressive disorders (MDD), 
bipolar disorders and anxiety (Simon et al., 2006). Despite obesity has been 
widely described as a multifactorial disease (Grundy, 1998), one of the most 
important aspect contributing to this pathology is to the capability of high-
palatable foods characterized by high amount of fats and/or sugars, typical of 
more recent western societies, to elicits addictive-like effects, leading to 
unintended overeating (Davis and Carter, 2009). This mechanism has been 
ascribed to the absorption signal coming from gut that, through the “gut-brain” 
axis, alter the DA activity and account for the rewarding properties of palatable 
food (de Araujo et al., 2012). In particular, the hormones leptin and ghrelin are the 
most investigated effectors of these signaling. Figlewicz and colleagues have 
shown that subcutaneous leptin can reverse the conditioned place preference for 
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sugar in food-restricted rats (Figlewicz et al., 2001) and, more recent evidence 
demonstrated that leptin induce its hypophagic effect through a mechanism 
involving DA D2 receptors (D2Rs) in the mesocorticolimbic pathway (Billes et 
al., 2012). Moreover, intracerebroventricular (i.c.v.) injection of leptin was 
demonstrated to attenuate the relapse to heroin in food restricted rats (Shalev et 
al., 2001). On the other hand, ghrelin was demonstrated to induce feeding 
behaviour when injected in the VTA or in the nucleus accumbens (Naleid et al., 
2005) and to increase the extracellular DA in the nucleus accumbens when 
administered in the VTA (Jerlhag et al., 2007). Moreover, ghrelin also has 
important effects on two more regions involved in feeding but also in learning and 
memory, i.e. the hippocampus and amygdala. In fact, it was reported to promote 
dendritic spine synapse formation and long-term potentiation (LTP) in 
hippocampus, enhancing spatial learning and memory (Diano et al., 2006). 
Furthermore, ghrelin suppressed anxiety-like behaviours when injected into 
amygdala of rats undergoing food abstinence period (Alvarez-Crespo et al., 2012).  
 
1.4.2 Food addiction in animal models 
Compulsive overeating as “food addiction” is a relatively recent construct 
introduced in the last decades to better characterize the pattern of abnormal eating 
disorders typical of obese and overweight people, firstly proposed by T. 
Randolph, the founder of environmental medicine, in 1956 (Randolph, 1956). 
Food addiction has been defined as a chronic and relapsing condition caused by 
the interaction of complex variables, which induces craving for high palatable 
food in order to reach energy, pleasure and excitement, or to relieve from negative 
situations (Imperatori et al., 2016). After initial skepticism on palatable food as an 
addictive substance, as testified by only six publications between 1950 and 1970, 
in more recent years this concept gained attention from media and researchers, 
leading to an increase of scientific literature. 
Addiction to highly palatable foods share a plenty of features with drug 
addiction. Functionally, they are both characterized by the release of 
neurotransmitters, such as endogenous opioids or DA, in the mesocorticolimbic 
pathway (Hernandez and Hoebel, 1988; Tanda and Di Chiara, 1998) or by the 
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activation of the same brain structures (DiLeone, Taylor and Picciotto, 2012). 
Moreover, they share also symptomatology, such as compulsivity, withdrawal and 
tolerance (Rogers, 2017). In the last decades, several studies pointed out the 
similarities between palatable food addiction and drug addiction. For example, 
rats showed a significant increase of DA and its metabolites 
dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the 
nucleus accumbens after 7 days of sucrose intake. Moreover, the pharmacological 
blockade of DA reuptake or D2Rs induced a significant increase in sucrose intake 
during test, similar to the effects induced by cocaine (Hajnal and Norgren, 2001; 
Corrigall and Coen, 1991; Bachtell et al., 2005). Finally, 7 days of restricted 
access to sucrose solution induced an increase of DAT protein in the nucleus 
accumbens and ventral tegmental area and of DAT mRNA level in the ventral 
tegmental area, similarly to cocaine effects (Bello et al., 2003; Zhu and Reith, 
2008). Johnson and Kenny in 2010, in order to investigate the effects of restricted 
or extended access to an obesity-inducing high-calorie diet, i.e. cafeteria diet, 
compared to no-access, implanted male rats with bipolar stimulating electrode 
into the posterior lateral hypothalamus and trained them to self-stimulation. After 
self-stimulation baseline establishment and measured as brain stimulation reward 
(BSR), rats were exposed to high-calorie foods. During 40 consecutive days of 
access to cafeteria diet, authors showed that rats with extended access had a 
marked deficit in reward function, measured as increased threshold for BSR. 
Similar deficits were previously reported for rats with extended access to cocaine 
(Ahmed et al., 2002) or heroin (Kenny et al., 2006) intravenous self-
administration (S/A), supporting the parallelism between food and drug addiction. 
After 40 days of exposure, rats were cafeteria-diet deprived and leaved with only 
normal chows. During this phase of forced abstinence, rats previously exposed to 
extended access to cafeteria diet showed a persistent elevation in reward 
threshold, lasting for at least 14 days, a much more longer period compared to 
reward deficit duration induced by cocaine S/A forced abstinence (~48h) (Markou 
and Koob, 1991). Furthermore, the compulsivity to cafeteria diet consumption 
was insensible to cue predicting punishment, i.e. footshock, for rat with a history 
of extensive access, compared to no access or restricted access. This result 
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revealed that food seeking resembles drug seeking, showing compulsivity even 
with negative consequences (Deroche-Gamonet et al., 2004). Finally, molecular 
analysis found that striatal level of membrane-bound D2Rs was significantly 
decreased in rats with the extended access to cafeteria diet, a neuroadaptive 
response to overconsumption of palatable food probably underlying the 
impairment of reward system function already seen also for substance use 
disorders (Johnson and Kenny, 2010). Oswald and colleagues obtained similar 
results in 2011, when they demonstrated that binge-eating prone rats were more 
resistant to footshock for obtaining highly palatable food than binge-eating 
resistant controls (Oswald et al., 2011). Binge-eating on food was also reported to 
induce cross-sensitization, an effect usually observed for drug of abuse (McDaid 
et al., 2005): in fact, a low dose of amphetamine (0.5 mg/kg ip) increased 
locomotor activity in rats previously experienced to bingeing on sugar, with no 
effect in naïve animals (Avena and Hoebel, 2003a). Moreover, even the opposite 
cross-sensitization was reported, as rats injected with 3 mg/kg ip amphetamine 
daily for 6 days demonstrated a cross-sensitization for 10% sucrose solution 
measured as hyperlocomotion and increased sucrose intake, an effect that persists 
for 5 days (Avena and Hoebel, 2003b). In mice, bingeing on sugar was 
demonstrated to cross-sensitize to 10 mg/kg ip cocaine and to 20 mg/kg ip 
morphine, as shown by the increase in locomotor activity after drug injection in 
mice previously conditioned to sweetened pellets, compared to control groups (Le 
Merrer and Stephens, 2006). Moreover, rats previously exposed to 12-h access to 
10% sucrose solution for 21 days and then leaved in sucrose abstinence for 3 
days, showed an increased intake of 9% ethanol solution during test on the 
following day. These results demonstrated that sugar could be a gateway for 
bingeing on alcohol, a phenomenon called “gateway effect” (Avena et al., 2004). 
In Colantuoni et al. (2002) rats were exposed to sugar bingeing for eight 
continuous days, and then sugar deprived. After 12 h of sugar fasting followed by 
naloxone (opiate antagonist, 20 mg/kg ip), rats showed the emergence of anxiety-
related symptoms like teeth chattering, forepaw tremors and head shaking. 
Naloxone after food deprivation reduced the time spent in the open arms during 
an elevated plus maze test and induced and imbalance in DA/acetylcholine (ACh) 
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level in the nucleus accumbens. Moreover, authors demonstrated that anxiety-
related symptoms emerged spontaneously after 24 h of sugar deprivation, and 
were observed again at 36 h, resembling opiate withdrawal effects induced by 
naloxone and suggesting that sugar addiction could be mediated, at least in part, 
by an endogenous opioids dependence (Colantuoni et al., 2002). Similar effects 
were reported also in Avena et al. (2008), where extended (28 days) sugar 
bingeing followed by food abstinence induced anxiety, as indicated by elevated 
plus-maze test, after 36 h of fasting (Avena et al., 2008). Moreover, the same rats 
exhibited a significant decrease of extracellular DA and a significant increase of 
extracellular ACh levels in the nucleus accumbens during abstinence, resembling 
effects induce by withdrawal from many drugs of abuse, such as morphine, 
amphetamine, nicotine and ethanol (Rossetti et al., 1992; Bickerdike and 
Abercrombie, 1997; Rada et al., 1991). An animal model of addiction-like eating 
behaviour demonstrated that, when stressed, rats prone to binge-eating disorders 
were more inclined to overeat highly processed food instead of normal chow, 
similar to stress-induced relapse on drug abuse (Boggiano et al., 2007; Shaham et 
al., 2000). Finally, a milestone publication in 2007 depicted the possibility that 
sweet palatable food overcome the addiction to drug, further clarifying previous 
evidence showing that concurrent access to highly sweetened water (a solution of 
glucose and saccharin) can alter cocaine self-administration (0.2 mg/kg iv) in rats 
(Carroll et al., 1989; Carroll and Lac, 1993). In particular, authors reported that a 
0.2%-saccharin solution, an intense calorie-free sweetener, as well as 4%-sucrose 
solution, were preferred to intravenous cocaine self-administration (0.25 mg/kg). 
The preference for saccharin was stable even with: i) increasing doses of cocaine 
(up to 1.5 mg/kg), ii) with delayed rewarding effects or iii) with increasing reward 
price, and it was rapidly and stably acquired even after 3 weeks of extended 
access (6 h/day) to cocaine self-administration (Lenoir et al., 2007). 
As reported above, sugar addiction can go through the different stages of 
addiction cycle described in the previous paragraph. Besides bingeing on sugar 
and the subsequent withdrawal accompanied by anxiety, cross-sensitization and 
gateway effect, animal models could finally experience craving after sugar 
abstinence, typical of the last preoccupation/anticipation stage. In Avena et al. 
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(2005), authors trained rats for sugar self-administration in an operant chamber 
using an FR1 instrumental learning schedule, consisting on the association 
between pressing on a lever and the delivery of 0.1 mL of 25% sucrose solution 
for each pressure. Training last 30 minutes daily for all the rats; however, only 
half of the animals had access to 25% sucrose solution for 11.5 more h each day 
(extended access). After 28 days of sucrose exposure, animals were sugar fasted 
for 2 weeks and 24 h later, craving on sucrose was evaluated through a 30-
minutes session in the operant chamber equipped with levers. Authors observed 
that after abstinence rats with extended access exhibit a higher craving compared 
to non-extended access group, as measured by increased responding on lever 
during test (Avena et al., 2005). This effect, called incubation of reward craving, 
is dependent on the duration of withdrawal and has been already observed for 
drug of abuse such as cocaine, nicotine, heroin, alcohol and methamphetamine 
(Pickens et al., 2011). Similarly to Avena and colleagues, Grimm and co-authors 
demonstrated that 15 days (Grimm et al., 2002) or 30 days (Grimm et al., 2005) of 
abstinence increased craving for sucrose compared to only 1 day, as shown by the 
increased number of active lever presses during cue-induced reinstatement test the 
day after withdrawal end. Noteworthy, an early report demonstrating incubation 
of craving for food in rats and its dependence on withdrawal duration has been 
published in 1938 by Youtz (Youtz, 1938).  
Despite an extensive literature about sugar bingeing and its addiction-like 
effects on animal models, data regarding binge eating of high fat diet are unclear. 
As for sugar, limited exposure to fat was able to induce extracellular release of 
DA in the nucleus accumbens of rats (Liang et al., 2006). Moreover, ad libitum 
access to fat seem to produces addictive-like behaviours, such as hyperarousal, 
increased stress and anxiety when ablated from diet (Teegarden and Bale, 2007). 
However, after limited access (bingeing) to high fat diet for 21-25 days, rats 
treated with naloxone (3 mg/kg sc) or fat-rich food deprived for 24-36 h did not 
shown the opiate-like withdrawal features already observed by Colantuoni and 
colleagues in 2002 or by Avena and colleagues in 2008. These differences 
between sugar and fat-induced addictive-like properties were explained through 
the action of the neuropeptide galanin (GAL), a peptide produced in response to 
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high-fat meal and hypothesized to be involved in the regulation and attenuation of 
behavioural and neurochemical effects of opiate reward (Zachariou et al., 2003; 
Hawes et al., 2008). Accordingly, the lack of effects observed in the previously 
mentioned publications could be caused by galanin activation, which in turn can 
inhibit opioid-like withdrawal effects usually observed after fasting of sugar 
bingeing (Avena et al., 2009).  
 
1.4.3 Food addiction in humans 
The features of food most likely involved in causing addiction-like effects in 
humans have been widely investigated by Schultze, Avena and Gearhardt in 2015, 
based on a parallelism with typical pharmacokinetic features of a drug of abuse. 
As reported in literature, alteration and processing of a substance are important 
steps in order to concentrate dose, and therefore increase potency and abuse 
potential (Henningfield and Keenan, 1993). In line with this previous observation, 
the level of processing, i.e. addition of fats and/or refined sugars appeared to be a 
key feature to define a food as liable of addictive-like behaviour.  Moreover, 
another hallmark of addictive agent is the rate of absorption into the blood flow 
(Verebey and Gold, 1988). In case of a food, the glycemic load (GL), accounting 
for the blood sugar spike in relation to carbohydrate content, was positively 
associated to likelihood of developing abnormal eating disorders toward 
carbohydrates (Schulte et al., 2015). 
Food addiction has been defined as a chronic and relapsing condition caused 
by the interaction of many complex variables that increase craving for specific 
foods, in order to achieve a state of high pleasure, energy or excitement, or to 
relieve negative emotional or physical states (Zou et al., 2017). This definition 
arises from drug addiction criteria listed in the DSM-V (American Psychiatric 
Association, 2013), that include: 
1) Taking the substance in larger amount and for longer period than was 
intended; 
2) Persistent desire or repeated unsuccessful efforts attempt to quit or 
control the substance use; 
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3) Large amount of time spent for activity necessary to obtain, to use or to 
recover from substance use; 
4) Important social, occupational, or recreational activities dismissed or 
reduced because of substance use; 
5) Continuative use despite the knowledge of adverse physical or 
psychological consequences; 
6) Tolerance, defines as the need to increase amount of substance to 
achieve desired effects, or as decrease of effects with continuous use of 
the same amount of substance; 
7) Withdrawal, express as withdrawal syndrome or as the need to use the 
same or similar substance to relieve or avoid abstinence symptoms. 
 
As for drug users, food addicted usually show a behavioural profile that resembles 
the aforementioned criteria, supporting analogy between substance use disorders 
and food addiction. The Yale Food Addiction Scale (YFAS), a 25-items self-
report questionnaire designed to identify eating patterns similar to behaviours seen 
in classic addiction, is based on the above criteria of DSM-V, and has been 
validated in US and many European Countries both in adults and children 
(Gearhardt et al., 2009; Gearhardt et al., 2013). Neuroimaging studies revealed 
that YFAS scores were positively correlated to brain activation in reward areas 
such as anterior cingulate cortex, orbitofrontal cortex and amygdala in response to 
anticipation of palatable food intake. Moreover, highly food-addicted patients 
showed less activation in the orbitofrontal cortex during food intake compared to 
low addicted. These results were in line with previous evidence of blunted DA 
response and corresponding weaker reward for substance abusers, associated with 
a decrease of D2Rs in striatal region (Gearhardt et al., 2011). Furthermore, Wu 
and colleagues in 2017 reported a decrease of DA transporters (DAT) in striatal 
region, as well as mRNA downregulation of DAT and tyrosine hydroxylase (TH), 
the enzyme regulating DA concentrations, in the substantia nigra of post-mortem 
obese brains vs controls (Wu et al., 2017). Finally, even though vast majority of 
animal study emphasize sugar-rich foods as the main responsible for binge eating 
disorders (Avena et al., 2009), a recent paper by Markus and colleagues 
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highlighted the importance of fat for the palatability related to “addiction-like” 
problems in humans. In fact, analyzing the relationship between YFAS scores and 
the kind of food mostly related to own “addictive” features, authors showed that 
high-fat savory foods (HFSA), such as cheese, chips and meat, and the high-fat 
sweet foods (HFSW), like chocolate and cake, were indicated as the most 
problematic, compared to low-fat tasty and only sugar-containing foods. 
Moreover, both BMI and BDI (Beck Depression Inventory, a validated 21-item 
self-report questionnaire evaluating depressive symptoms) scores were positively 
correlated with HFSA and HFSW, bringing back the attention on the possible role 
of fat on the induction of food addiction and opposing to the negative evidence for 
fat-rich food withdrawal reported for murine models  (Markus et al., 2017).  In 
light of these behavioural and molecular data, both in murine models or humans, 
is nowadays widely accept to ascribe food addiction to substance use disorders, 
pathologies characterized by an initial phase of bingeing on substance, and then 
precipitation to loss of control, tolerance and abstinence, craving and a final 
relapse to abuse (Koob and Volkow, 2016). Recently, clinical treatment studies 
showed that more than 85% of individuals relapse to alcohol, nicotine or illicit 
drug abuse within one year of treatment, and more than two thirds of individuals 
within weeks or months (Sinha, 2013), clearly demonstrating the lack of long-
term successful treatment for addiction disorders. 
 
1.5 Memory processing: from learning to reconsolidation 
Memory is a sequence of separate and distinct phases, each one characterized 
by different molecular and circuital mechanisms responding to specific cognitive 
requirement. The first phase is the learning phase (I), during which new 
information are acquired by new experiences and stored as new memory traces. 
New memories are initially unstable, and need consolidation (II), a 
neurobiological active phase based on protein synthesis, LTP and receptor 
trafficking, to be stabilized and strengthened. Moreover, in order to avoid being 
forgotten, memory need another sustaining process called maintenance (III) that 
stabilized synaptic connection supporting memory traces. This process also permit 
memory retrieval (IV) that is the recall of stored information in order to help 
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guiding individual’s behaviour, one of the main purpose of memory (Miller and 
Springer, 1973). Consolidation cover a time window of several hours, and once 
stored memory was believed to become static and stable for as long as it persisted 
(Squire, 1984). For more than 100 years, the idea that once consolidated 
memories become stably stored in the brain has been a dogma, supported by 
several line of evidence. In fact, memory was shown to be compromised whether 
amnestic treatments such us electroconvulsive shock (ECS, Duncan, 1949), 
protein synthesis inhibitors (PSI, Flexner et al., 1965) or new competing learned 
information (Gordon and Spear, 1973) were presented after initial learning. On 
the other hand, memory maintenance could be improved by different treatments, 
such as strychnine (McGaugh and Krivanek, 1970), cholecystokinin receptors 
activation (Flood and Morley, 1989) or drug of abuse like amphetamine (Lee and 
Ma, 1995). Noteworthy, these treatments were effective only during a limited 
period after memory acquisition but not when delayed in time, leading to the 
distinction between short-term memory and long-term memory, unstable and 
sensitive to interferences the former, stable and insensitive the latter (Haubrich 
and Nader, 2016).  
Consolidation theory and the view of retrieval simply as a passive access to 
previously consolidated memory were challenged since the initial conception. 
Milestone studies by Misanin, Miller and Lewis and by Schneider and Sherman in 
1968 demonstrated that rats had fear memory impairment when they received 
ECS 24 h after the initial fear conditioning and shortly after memory retrieval 
through fear-conditioned stimulus (CS) presentation (Lewis et al., 1968; Misanin 
et al., 1968; Schneider and Sherman, 1968). Moreover, this memory impairment 
was induced also by competition with new information presented shortly after 
retrieval (Gordon, 1977), an amnestic treatment effective only when administrated 
within a defined time window. These amnesic effects were not in line with the 
previous view of retrieval as a simple passive re-access to static and stable 
consolidated memory, leading scientists to theorized a new phase of memory 
processing, i.e. memory reconsolidation (V), that is an active process need to re-
stabilize and maintain previously reactivated memory traces (Figure 5). 
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Figure 5: The first and the more recent model of memory processing. (A) The first 
model, with the initial learning codified in a short-term memory that will 
consolidate in a long-term stabile and unchangeable memory trace. (B) The new 
model of memory processing, where after the initial codification in a short-term 
memory (active state) the memory is then stabilized in a long-lasting inactive state 
(long-term memory). However, a retrieval session can return memory trace from 
the inactive state to a new active state, requiring a new reconsolidating phase to 
return a stable memory engram. Taken and adapted from Nader, 2003.     
 
 
1.6 Memory reconsolidation 
After its initial conceptualization, memory reconsolidation received modest 
investigation for many years, until a milestone publication in 2000 by Nader and 
colleagues (Nader et al., 2000). In this paper, authors used a well-characterized 
behavioural protocol, i.e. auditory fear conditioning, and anisomycin (ANI), an 
antibiotic known for its amnesic effect on long-term auditory fear memory 
through inhibition of protein synthesis. After fear memory retrieval with CS, rats 
received bilateral infusion of ANI into the basolateral amygdala, a brain region 
important for emotional information processing. The treatment with ANI was able 
to impair long-term, but not short-term, memory retention as shown by test 24 h 
after retrieval. However, the treatment was effective only within a defined time 
window and specifically after retrieval, as the same treatment 6 h after CS 
presentation or without CS presentation did not inhibit fear memory (Nader et al., 
 
27 
 
2000). Hence, the same evidence supporting consolidation as a stabilization 
process after learning supported also reconsolidation as a necessary restabilization 
phase after retrieval (Haubrich and Nader, 2016). In the past 10 years, the study of 
reconsolidation have been extended to numerous experimental paradigms and 
different animal species, as summarized in Table I.  The protocol for memory 
reconsolidation study typically go through the different phases described above: 
after an initial training phase, memory are reactivated, manipulated and finally 
tested for retention. Reactivation is usually induced by exposure to CS 
(unreinforced retrieval) and, more rarely, also to US (reinforced retrieval). In 
general, memory reconsolidation has been demonstrated rarely through its 
enhancing (Stern and Alberini, 2013), and much more often, through its inhibition 
(Lee, 2009; Tronson and Taylor, 2013). Whether behavioural (Xue et al., 2012), 
pharmacological (Nader et al., 2000) or genetic (Lee et al., 2004) manipulations 
applied after retrieval cause changes in behaviour, we can conclude that the active 
process of reconsolidation has been addressed.  
 
1.6.1 Molecular mechanisms in memory reconsolidation 
Different molecular mechanisms participate, at different level, to memory 
reconsolidation process. As already mentioned, protein synthesis is a key process 
for both consolidation and reconsolidation (Tronson and Taylor, 2007). Moreover, 
N-methyl-D-aspartate receptors (NMDARs), α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPARs) and β-adrenergic receptors (β-ARs) 
have been reported as key targets for pharmacological reconsolidation inhibition 
(Milton et al., 2008a; Bhattacharya et al., 2017; Fricks-Gleason and Marshall, 
2008). In addition, transcription factors (TFs) play a crucial role in memory 
reconsolidation. Cyclic AMP-response element binding protein (CREB) 
disruption in prefrontal cortex, hippocampus and amygdala is reported to impair 
memory reconsolidation of both auditory and contextual fear memory (Kida et al., 
2002). Lee and colleagues in 2004 described a double dissociation between brain-
derived neurotrophic factor (BDNF) and the TF zinc finger protein 268 (Zif268) 
involvement in consolidation and reconsolidation. Rats injected directly in the 
dorsal hippocampus with BDNF antisense oligodeoxynucleotides (ASO) 90 
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minutes before contextual fear conditioning resulted in a short-term (24 h after) 
and long-term (7 days after) impairment of contextual fear memory. This effect 
was not observed when infusion was done 90 minutes before memory retrieval or 
with Zif268 ASO, indicating a specific requirement of hippocampal BDNF for 
fear memory consolidation. Conversely, infusion of Zif268 ASO 90 minutes 
before memory reactivation resulted in amnesia during a post-retrieval LTM test, 
an effect that was not observed in the absence of a retrieval session or with 
infusion of BDNF ASO, indicating the specificity of Zif268 for fear memory 
reconsolidation (Lee et al., 2004). However, Zif268 is crucial not only for 
hippocampal-dependent memory reconsolidation, but also in basolateral amygdala 
for auditory fear memory (Hall et al., 2001) and for drug-associated memory 
reconsolidation (Milton et al., 2008b; Théberge et al., 2010). Another dissociation 
in consolidation and reconsolidation involvement has been demonstrated for 
C/EBPβ. While this TF is required in hippocampal-dependent consolidation, but 
not reconsolidation, of inhibitory avoidance (IA) learning, in amygdala it is 
involved in the reconsolidation, but not consolidation, of IA memory (Tronel et 
al., 2005). Lastly, important roles in memory reconsolidation are played also by 
kinases, such as extracellular signal-regulated kinase (ERK), protein kinase A 
(PKA), protein kinase C (PKC) or mechanistic target of rapamycin (mTOR). In 
particular, the mTORC1 (mTOR complex 1) cascade and its suppression by 
rapamycin has been linked to memory reconsolidation inhibition in different 
experimental paradigms, like contextual fear memory (Blundell et al., 2008), 
auditory fear memory (Tedesco et al., 2014b), alcohol-associated (Barak et al., 
2013) and cocaine-associated (Wang et al., 2010) instrumental memory. These 
evidences highlight the importance of this cascade and its downstream effectors 
p70S6K and rpS6 in memory reconsolidation, related to its role in de-novo protein 
synthesis locally in active synapses (Neasta et al, 2014; Pirbhoy et al., 2017) 
(Figure 6). 
All the information available nowadays about memory reconsolidation, from 
animal species to experimental tasks and molecular mechanisms, shed light on the 
fundamental role of this process. Act on the stability of memory, by an 
evolutionary point of view, it serves as an adaptive update mechanism allowing 
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for the integration of new information on the original memory traces (Hupbach et 
al., 2007) or even to strengthen them (Inda et al., 2011). However, such a delicate 
function should have boundary conditions defining the features of a retrieval 
session, in order to control tightly the parameters that induce labilization and thus 
destabilization of mnemonic engrams.  
 
 
Figure 6: Important pathways and molecular markers for memory reconsolidation. 
β-ARs and NMDARs are key receptors in molecular mechanisms of memory 
reconsolidation: through the influx of calcium ions, they could activate the 
MAPK/ERK pathway or protein kinase A (PKA), ending with the activation of 
cAMP response element-binding site (CREB) that stimulates the gene 
transcription of important protein, such as cFos, JunB or Zif268. Taken and 
adapted from Tronson and Taylor, 2007. 
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Table I: Experimental paradigms, amnestic treatments and species of 
reconsolidation studies. Taken and adapted from Haubrich and Nader, 2016. 
 
 
1.6.2 The boundary conditions of memory reconsolidation 
Not all the retrieval sessions can induce reactivation of the memory; there are 
important parameters, related to the intrinsic characteristics of the consolidated 
memory traces that determine whether that reactivation, destabilization and 
Experimental paradigm 
Auditory fear conditioning Nader et al., 2000 
Contextual fear conditioning Debiec et al., 2002 
Episodic memory Hupbach et al., 2007 
Habituation Rose and Rankin, 2006 
Inhibitory avoidance  Anokhin et al., 2002; Litvin and Anokhin, 2000 
Instrumental learning  
Hernandez and Kelley, 2004; Tedesco et al., 
2014a 
Incentive learning  Wang et al., 2005 
Positive reinforcement  Flavell et al., 2011 
Memory for drug reward  Lee et al., 2005; Milton et al., 2008a; 2008b 
Object recognition Kelly et al., 2003 
Spatial memory Suzuki et al., 2004 
Amnestic treatment 
Antisense oligonucleotides Lee et al., 2004; Taubenfeld et al., 2001 
Inhibition of kinase activity Duvarci et al., 2005, Kelly et al., 2003 
Inducible knockout mice Kida et al., 2002 
Interference by new learning  Hupbach et al., 2007, Walker et al., 2003 
Potentiated reconsolidation 
by increase in kinase activity 
Tronson et al., 2006 
Protein-synthesis inhibition  Nader et al., 2000 
Protein knockout mice  Bozon et al., 2003 
Receptor antagonists  Kindt et al., 2009; Suzuki et al., 2004 
RNA synthesis inhibition  Sangha et al., 2003 
Species 
Chick Anokhin et al., 2002 
Crabs  Pedreira et al., 2002 
Honeybees  Stollhoff et al., 2005 
Humans Hupbach et al., 2007; Walker et al., 2003 
Mice  Kida et al., 2002 
Rats  Nader et al., 2000 
Sea slugs  Child et al., 2003; Lee et al., 2012 
Sheep  Perrin et al., 2007 
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eventually reconsolidation will take place. These parameters, called “boundary 
conditions”, have received increasing attention in the last years as important 
determinants of whether memory is more or less susceptible to be reactivated and, 
possibly, disrupted (Auber et al., 2013). 
Two of the most important boundary conditions are memory age and retrieval 
duration. As reported in Frankland et al. (2006), when ANI was injected into the 
dorsal hippocampus of mice after memory retrieval by short context re-exposure, 
the expression of a recent (1-day old) contextual fear memory was blocked during 
a test 24 h later. The same infusion was not effective with a 36-day old memory or 
when context re-exposure (retrieval) was omitted. Conversely, infusion of ANI in 
the anterior cingulate cortex after short or extended context re-exposure was 
ineffective in blocking the expression of both 1-day and 36-day old contextual 
fear memory. Nevertheless, when ANI was injected systemically after an 
extended retrieval session, memory was disrupted in the test 24 h later. These 
results indicated that, while recent memory are located in more limited subcortical 
regions, like hippocampus, old memory are more widespread in the cortex and 
PSI need to be systemically injected to be effective. Moreover, in addition to the 
age of a memory, even the strength of the retrieval session is a boundary condition 
that can determine whether memory will be reactivated (Frankland et al., 2006). 
Bustos and colleagues obtained similar evidence in 2009, when they analyzed the 
effects of systemic midazolam (MDZ), a benzodiazepine effective in memory 
reconsolidation disruption, on contextual fear memory reconsolidation. They 
reported that in order to prevent the reconsolidation of increasingly old memories, 
they need to increase, in parallel, the duration of retrieval session and/or the MDZ 
dose after retrieval. However, an excessively prolonged non-reinforced retrieval 
session can induce extinction, defined as the establishment of a new competing 
memory trace where the originally association between CS and US is now 
replaced by CS-no reinforcement association (Bouton, 2004). Therefore, MDZ 
treatment following extinction resulted in the disruption of extinction 
consolidation, rather than reconsolidation inhibition (Bustos et al., 2009). 
In the elegant study by Wang et al. (2009), authors reported that also the length of 
training phase, and so the memory strength, is a determining parameter for 
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memory reactivation. In fact, 10 tone-shock pairings created a memory trace 
stronger to be reactivated and inhibited by ANI injection into basolateral 
amygdala then a single pairing. However, the inability of ANI to induce 
behavioural impairment was prevented only when retrieval was performed at 2 
and 7 days after strong training. When memory was reactivated 30 or 60 days 
after training, ANI was able to induce reconsolidation deficits. Moreover, in line 
with Frankland et al. (2006), when dorsal hippocampus was electrolytic lesioned 
before strong training, ANI infusion into basolateral amygdala following retrieval 
was able to block post retrieval-long term memory even at 2 days after training, 
indicating the fundamental and time-limited role of dorsal hippocampus in 
inhibiting re-access to strong memory traces. Finally, the authors identified 
GluN2B-containing NMDARs (GluN2B) as main regulators of the strength need 
to reactivate memory, with a decreased receptors level 2 days after strong training 
preventing reactivation, and a return to basal level after 60 days or following 
dorsal hippocampal lesion, allowing reactivation (Wang et al., 2009). Other 
boundary conditions reported to influence memory retrieval and reconsolidation 
are the reactivation context (Hupbach et al., 2008), the specificity of CS for the re-
accessed memory (Debiec et al., 2006) and the moment during which it is 
reactivated, i.e. during waking or during sleep (Diekelmann et al., 2011). Finally, 
it is noteworthy that the majority of boundary conditions are related to the feature 
of novelty: in fact, predictability seem to be one of the most important constraint 
for memory reconsolidation (Pedreira et al., 2004). Furthermore, the prediction 
error signal, defined as the signal elicited by the mismatch between the expected 
event and what actually happen, has been hypothesized as a key factor of a 
reminder for its capability in re-accessing and thus labilizing previously 
consolidated memory (Fernández et al., 2016).  
In conclusion, understanding the boundary conditions for memory reconsolidation 
is critical because targeting reconsolidation process has been proposed to be a 
potential treatment for maladaptive memory-related diseases, such as PTSD or 
substance use disorders. Therefore, if molecular or cellular markers linked to 
boundary conditions will be clearly identified, they could be helpful to recognize 
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the optimal retrieval condition and predicting success or failure of memory 
reactivation procedure.  
 
1.6.3 Pavlovian vs instrumental memory 
Pavlovian (or classical) and instrumental (or operant) conditioning are two 
important concepts of behavioural neuropsychology, concerning different 
methods of learning and behavioural modulation in animal models.  
Pavlovian conditioning was firstly theorized by the Russian physiologist Ivan 
Pavlov in 1902, observing the salivation reflex of his dog in response to food 
(Pavlov, 1927). In fact, the classical conditioning consists in the presentation of a 
neutral signal, like a sound, an odor or a light before an unconditioned stimulus 
(US). An US is a stimulus that possess positive (like food) or negative (like a mild 
shock) reinforcing properties per sé able to generate a reflex response. After a 
period of neutral signal followed by US presentation, the neutral signal will be 
associated to the US and will generate the reflex response on its own, without the 
presentation of the original US. Therefore, with the classical conditioning it is 
possible to couple a neutral stimulus with a reinforcement, generating a 
conditioned response (CR, salivation for food or freezing for footshock) toward 
the neutral signal that will eventually became a conditioned stimulus (CS) 
(McSweeney and Murphy, 2014). 
Instrumental conditioning instead has been firstly described by the American 
psychologist Burrhus Frederic Skinner in 1938 (Skinner, 1938). Here, the 
association is between an action and a succeeding positive or negative outcome, 
and the experiments are usually performed in a conditioning box, also known as 
Skinner box (Figure 7). A positive outcome, namely a reinforcement, will increase 
the motivation toward repeating the action, while a negative outcome, namely a 
punishment, will weaken the behaviour, decreasing the probability of the action 
being repeated. Reinforcement can be either positive or negative: a positive 
reinforcement, like food, is something that an individual finds rewarding, while a 
negative reinforcement consists in the removal of an uncomfortable situation, like 
being exposed to the sunlight for a rat. Avoiding the uncomfortable situation 
generates a sort of “reward” for the individual, strengthening that behaviour.  
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For rat or mouse conditioning, it is possible to use different patterns of 
reinforcement in order to modulate the speed and strength with which an 
instrumental conditioning is acquired. These patterns are experimentally called 
schedules, and can be fixed- or variable-ratio schedules. With a fixed-ratio (FR) 
schedule, the reinforcement is acquired following a fixed number of time the 
action is completed, like 10 lever presses to obtain a pellet (FR10); conversely, 
with a variable-ratio (VR) schedule, the reinforcement is acquired after a variable 
number of time the action is completed, like between 12 and 25 lever presses to 
obtain a pellet (VR20). Moreover, there are also fixed- or variable-interval 
schedules, during which the reward is obtained after a fixed or variable interval of 
time. These schedules have different effects on the rate of responding and the rate 
of extinction of the trained animals, with variable-ratio schedules supposed to 
create more resistant memory traces because of unpredictability of reinforcement 
(McLeod, 2007). However, also the number and duration of the training trials 
carried out during the learning phase regulate the memory strength, rendering the 
memory trace more or less susceptible to changes mediated by behavioural or 
pharmacological manipulations. 
 
 
Figure 7: A typical conditioning box. Coupling the lever pressing (on the center of 
frontal wall) with pellets delivery (on the right of the frontal wall) in presence or 
in absence of a CS can induce respectively pavlovian instrumental or pure 
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instrumental conditioning. Here it is also possible to produce a classical 
conditioning, coupling a tone or a light stimulus (CS, above the lever) with a 
pellet delivery or a footshock (delivered by the electric grid floor). Taken from 
McLeod, 2007.  
 
 
1.6.4 Sucrose instrumental memory reconsolidation 
Memory reconsolidation for high palatable food has been investigated using 
the experimental protocols typically applied to study drug addiction memory. One 
of these protocols has been already mentioned above in the paragraph 1.4.2 and 
used in Grimm et al. (2002, 2005) and Avena et al. (2005). It follows the normal 
progression of drug addiction, i.e. an initial bingeing on sucrose, a subsequent 
withdrawal phase with incubation of reward craving and finally sucrose craving 
and taking evaluation through memory extinction and reinstatement tests. In 
Grimm et al. (2002) after 10 days of training to lever presses for sucrose 
associated to tone + light cues, rats underwent 1 or 15 days of withdrawal 
followed by extinction sessions and memory reconsolidation test. Authors 
observed that, resembling cocaine memory, sucrose instrumental responding 
associated to CS exposure was more resistant to erasure after 15 days than 1 day 
of withdrawal, demonstrating the incubation of craving for sucrose (Grimm et al., 
2002). Then, Hernandez and colleagues have done a similar study in the same 
year on sugar instrumental memory consolidation and reconsolidation. To study 
the requirement of protein synthesis for food memory consolidation, researchers 
trained rats to self-administer sugar pellets with a daily session of 15 minutes for 
12 days. During the session, rats in the operant chambers received a sugar pellets 
every two lever presses on the active lever (FR2). A second, inactive lever had no 
consequence. A red light (CS) was associated to sugar pellets delivery. When ANI 
(62.5 μg) was injected directly in the nucleus accumbens core of rats immediately 
after each one of the first five daily trials, authors reported a significant 
impairment of learning, concluding that protein synthesis is required for sugar 
memory consolidation. Same injection in the nucleus accumbens shell did not 
induce significant effect. Instead, when ANI was injected in nucleus accumbens 
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core immediately after the last trial sessions (day 9, 10 and 11), researchers did 
not observed learning impairment, concluding that protein synthesis was not need 
for food memory reconsolidation (Hernandez et al., 2002). However, the 
experimental protocol did not contemplate a distinct withdrawal or retrieval 
sessions, with the latter necessary for the labilization of the memory trace and 
hence for memory reconsolidation manipulation. Similar results were obtained by 
the same authors in a following report. Here, researchers treated rats with 20 
mg/kg ip ANI during the last sessions of sugar instrumental training and observed 
a decrease in responding on levers that was lately addressed to the development of 
conditioned taste aversion for sugar rather than to sugar memory reconsolidation 
inhibition. In this case, memory retrieval after training was induced by non-
contingent exposure to sugar boluses consumption (US without CS); however, the 
protocol still lack of a clear withdrawal period that could induce craving 
incubation. Therefore, the lack of reconsolidation inhibition was referred to a 
possible overtraining that strengthened memory trace to a protein synthesis-
independent level - a condition that can explain also the lack of results in 
Hernandez et al., 2002 - or to the inability of the current approach using US as 
retrieval to disrupt memory reconsolidation (Hernandez and Kelly, 2004). 
Two more publications in 2005 investigated the incubation of craving for sucrose: 
Grimm et al. extended the previous evidence reporting that craving for sucrose 
was increased after 30 days of fasting, compared to 1 or 7 days (Grimm et al., 
2005). On the other hand, Avena et al. reported that rats with an history of 
extensive sucrose bingeing showed enhanced intake after 14 days of abstinence, 
compared to rats having short access to sucrose, suggesting that sucrose bingeing 
could induces behavioural changes indicative of addiction-like alterations (Avena 
et al., 2005). Reconsolidation of instrumental learning for sucrose was firstly 
demonstrated by Wang and colleagues in 2005. Using a protocol of incentive 
learning, authors initially associated a sucrose solution to left lever and sucrose 
pellets to right lever (or vice versa) inside an operant chamber (training phase). 
Twenty-four hours later, rats were ad libitum exposed to sucrose for reward 
devaluation followed by intra-basolateral amygdala infusion of vehicle (VEH) or 
ANI and, the day after, tested for memory consolidation. After consolidation test, 
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groups were re-exposed to the devaluated reward, treated with the opposite drug 
(before VEH, then ANI (V/A) or before ANI, then VEH (A/V)) and the day after, 
tested for reconsolidation. As expected, ANI inhibited consolidation and thus 
reward devaluation during the first test, compared to VEH. The second test 
instead demonstrated that even memory reconsolidation is ANI-sensitive and thus 
dependent on protein synthesis, as reward re-exposure (retrieval session) followed 
by ANI blocked incentive learning and induced reconsolidation inhibition at the 
final test (Wang et al., 2005). 
Instrumental memory reconsolidation for sucrose has been shown to depend on β-
ARs through their inhibition with propranolol injection (10 mg/kg ip) immediately 
after retrieval (Diergaarde et al., 2006; Milton et al., 2008b); moreover, it has been 
disrupted also with MK-801 injection (0.1 mg/kg ip) 30 minutes prior to retrieval 
(Lee and Everitt, 2008b). In the latter study, memory reactivation was performed 
by exposure to an experimental session identical to training trials, except for the 
lack of sucrose US. The importance of retrieval setting was investigated by the 
same authors in another publication of 2008: here, Lee and Everitt used an 
experimental protocol similar to the previous study, but reactivation was 
performed with CS presentation both contingently and non-contingently to active 
lever pressing, besides US absence. Interestingly, in addition to confirm pre-
reactivation MK-801 efficacy in successive reconsolidation inhibition, they 
reported that only when CS presentation was given contingently upon active lever 
press memory was actually reactivated, and MK-801 could inhibit reconsolidation 
during test. Conversely, when CS was presented in the absence of levers, MK-801 
was ineffective to block reconsolidation, whether injected before or after 
reactivation. These results shed light on the importance of salient memory-
evoking stimuli presentation for the targeting of memory reconsolidation as 
therapeutic tool for addictive behaviours (Lee and Everitt, 2008a). A third paper 
by Lee and Everitt in 2008 demonstrated that Pavlovian representation at the 
bases of a Pavlovian-instrumental transfer (PIT) undergo NMDARs-dependent 
reconsolidation, as MK-801, but not propranolol, injection 30 min before CS re-
exposure reduced instrumental responding in a subsequent test (Lee and Everitt, 
2008c).  
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Mierzejewski and colleagues in 2008 were able to alter appetitive operant 
conditioning for saccharin through subcutaneous injection of the protein synthesis 
inhibitor cycloheximide (CHX). After self-administration training, during which 
rats associated active lever presses with a CS and saccharin rewards, animals 
underwent multiple extinction sessions with subcutaneous CHX 3mg/kg or VEH 
treatments immediately after each session. Extinction could be 5-min or 30-min 
long and was characterized only by operant box exposure (context) equipped with 
levers, without CS or US presentation. Authors observed that with 5-min 
extinction sessions animals extinguished operant behaviour faster than controls. 
Conversely, with 30-min sessions animals did not extinguished, rather they 
increased operant responding on active lever. These results highlighted the 
importance of retrieval session features: considering the first extinction session as 
a brief (5 min) or extended (30 min) reactivation, researchers concluded that a 5-
min exposure to context + levers followed by CHX was able to inhibit 
instrumental memory reconsolidation, while a 30-min exposure followed by CHX 
inhibited the consolidation of the new extinction memory. Noteworthy, extinction 
sessions were characterized by novelty, as differently from training it did not 
exposed rats to CS or US (Mierzejewski et al., 2008). Nevertheless, the same 
authors in a 2009 reported that, following the same experimental protocol, 
instrumental memory did not underwent reconsolidation inhibition through CHX 
injection (Mierzejewski et al., 2009). However, here extinction sessions were 
replaced by 5-min long self-administration trials including US and CS 
presentation, thus losing the features of novelty previously reported. Instead, this 
last protocol could be considered simply as a long-lasting self-administration 
phase, which was already reported as de novo protein synthesis-independent by 
Hernandez and Kelly in 2004.  
The balance between reconsolidation and extinction in an appetitive instrumental 
memory task was assessed by Flavell and Lee in 2013. After a 5-day training 
during which rats learned to associate active lever presses to sucrose and CS, and 
3 days of abstinence, animals received MK-801 (0.1 mg/kg ip) or vehicle 30 min 
before memory retrieval. Different groups underwent different retrieval sessions: 
pure instrumental group was reactivated only with lever pressing for a maximum 
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of 10 or 50 pressures, while Pavlovian + instrumental group was reactivated with 
CS presentation upon active lever responding. This last was further divided in 
three subgroups on the bases of CS exposure during reactivation: the first 
subgroup was allowed to press lever to receive up to 10 CS, the second up to 30, 
and the third up to 50. A separate group of rats was treated with MK-801 or 
vehicle in the home cage as a control (no-retrieval group). Memory test was 
performed 48 h later. Results demonstrated that MK-801 affected behaviour at test 
only when injected before 10 or 50 CS retrieval session, without difference 
compared to vehicle when injected before no-retrieval, before 30 CS presentation 
and 10-presses or 50-presses pure instrumental retrieval groups. Specifically, 
when injected before 10 CS presentation, instrumental memory was reported to be 
impaired during test, while it was enhanced when MK-801 was injected before 50 
CS exposure. Based on previous literature about fear and other appetitive 
memories, authors concluded that a brief CS exposure triggered destabilization 
leading to reconsolidation, and the NMDARs antagonism inhibited this process 
leading to reconsolidation inhibition. Conversely, prolonged exposure to CS 
induced consolidation of a new extinction learning, and its inhibition with MK-
801 treatment leaded to the reconsolidation and strengthening of the original 
memory trace (Flavell and Lee, 2013).  
In the studies reported so far, only Mierzejewski et al. (2008) showed that pure 
instrumental memory reconsolidation could be inhibited by PSIs, while Flavell 
and Lee (2013) reported that memory reconsolidation is not affected by MK-801. 
However, Exton-McGuinness and colleagues in 2014 firstly demonstrated that 
also MK-801 could inhibit pure instrumental memory reconsolidation. In this 
paper, authors demonstrated that a well-learned 10-day pure instrumental memory 
was correctly reactivated with a VR20 retrieval session. During training, pellets 
were administrated under an FR1 schedule; however, during reinforced retrieval 
session, the number of active lever presses need to acquire a reward was variable 
and, specifically, rats received sucrose pellets after a mean of 20 active lever 
presses, in a range between a minimum of 12 and a maximum of 28 presses. 
Thirty minutes before reactivation, rats were treated intraperitoneally with MK-
801 0.1 mg/kg or vehicle. MK-801 prior to VR20-reactivation significantly 
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decrease instrumental responding during a 30-min extinction test the day after 
retrieval. As control, separate groups of rats received a brief non-reinforced 
retrieval session, a FR20-reinforced retrieval session and a no-reactivation 
session. In all these control groups, MK-801 before memory reactivation did not 
impaired reconsolidation during test, suggesting that memory trace was not 
correctly destabilize. Moreover, authors proved that this effect was specific for 
reconsolidation inhibition and not referable to a devaluation of reward or to a 
reduction in general activity or motivation (Exton-McGuinness et al., 2014). 
Furthermore, Exton-McGuinness and Lee in 2015 expand the evidence of pure 
instrumental memory reconsolidation to 2-d weakly trained lever-pressing 
memory. Here, authors showed that MK-801 (0.1 mg/kg ip) 30 min before a VR5 
reactivation session was able to impair reconsolidation in a 30-min test the day 
after. As before, they demonstrated that a non-reinforced or a fixed-ratio (FR1) 
reactivation did not exert the same effect as a variable-ratio session. Finally, they 
demonstrated also the involvement of accumbal NMDARs and D1Rs in the 
memory reconsolidation process. Immediately before VR20-reactivation, AP-5 
(NMDARs antagonist) and SCH23390 (D1Rs antagonist) were injected into the 
nucleus accumbens individually or combined. As observed in the test 24 h later, 
only the co-infusion was effective in disrupting reconsolidation, while intra-
accumbens AP-5, SCH23390 or MK-801 alone did not reduce instrumental 
responding. In conclusion, authors pointed out the need of a shift in reinforcement 
contingency during retrieval, which can lead to a prediction error signal assumed 
to be a critical determinant for the labilization of a consolidated memory trace 
(Exton-McGuinness and Lee, 2015). 
To conclude, it is important to note that some recent studies have analyzed 
also the possibility to disrupt memories applying an extinction training after 
reactivation, using the memory-updating function of the reconsolidation process 
to investigate the possible therapeutic aspect of erasing a maladaptive conditioned 
response. Flavell, Barber and Lee in 2011 demonstrated that extinction applied 1 
hour after a reactivation session induced a long-lasting impairment in the 
acquisition of a new instrumental response, using a protocol of reactivation + 
extinction demonstrated to be effective in attenuating fear conditioning (Monfils 
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et al., 2009). Initially, rats were trained for 20 minutes over 9 days to nosepoke 
into a food magazine to receive sugar pellets with an FR1 schedule, and the 
nosepokes were coupled with the presentation of a light stimulus (CS). Twenty-
four hours after training, memory was reactivated by a 10-min extinction training, 
identical to training trials except that nosepokes did not delivered pellets. One or 
six hours after retrieval, memory was extinguished with a 60-min extinction 
training, and tested for the acquisition of a new instrumental response on levers at 
1, 2, 5, 8, 13, 20 and 27 days later. During tests, pressing the active lever on the 
opposite side of the training CS resulted in the CS light stimulus, while a 
nosepoke or pressing the inactive lever in the same side of CS resulted in no 
consequence. In particular, at test day 1, 2, 3 and 5 CSs were presented with an 
FR1 schedule, while at day 13 and 20 the schedule was FR3 to increase the 
probability of spontaneous recovery. The final test at day 27 was a reinstatement 
test, as 10 sugar pellets were available in the training context before test. When 
presented 1 h after retrieval the extinction session was able to impair the 
acquisition of a new instrumental response during tests. Moreover, memory was 
impaired until the last reinstatement test, demonstrating that it did not recover 
during subsequent tests nor reinstated by sucrose exposure. However, as for fear 
memory (Nader et al., 2000), reconsolidation has a limited time windows, as 
applying extinction 6 h after reactivation did not result in memory impairment. 
Finally, researchers noted some differences compared to fear memory; in fact, the 
simple exposure to the training context was able to reactivate correctly the 
memory, as an extinction session after context exposure resulted in a memory 
impairment similar as after CS retrieval. This was in contrast with previous 
findings (Monfils et al., 2009), arguing that in appetitive setting the conditioning 
context could act as an “occasion setter”, contributing to the ability of the CS in 
modulating the behaviour. Moreover, an injection of d-cycloserine (DCS), a 
partial NMDARs agonist, instead of retrieval, 1 h before extinction did not impair 
the new response acquisition during tests, in contrast with previous evidence for 
fear memory (Ledgerwood et al., 2004). DCS was supposed to enhance 
extinction, and the lack of effects leads the authors to posit that the effect 
observed after reactivation followed by extinction was due to the specific effect of 
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retrieval in inducing destabilization, rather than potentiating extinction learning 
(Flavell et al., 2011). Notably, DCS was able to enhance extinction of cocaine 
self-administration (Thanos et al., 2011). Finally, a cued retrieval session followed 
by extinction within six hours was able to impair heroin seeking in both rats and 
humans (Xue et al., 2012), demonstrating that this procedure could have 
significant therapeutic impacts for the treatment of maladaptive memory diseases 
like PTSD and substance or non-substance addiction.  
 
1.7 The concept of metaplasticity 
In the late 1990s, studying the mechanisms of long-term potentiation (LTP) 
and long-term depression (LTD), basic for the induction of long-lasting synaptic 
plasticity strengthening (the former) or weakening (the latter), W.C. Abraham and 
M.F. Bear defined a new concept, that they called metaplasticity. They found that 
weak synaptic stimulations, even causing only a transient or null potentiation per 
sé, were able to strongly influence future synaptic events, like potentiation or 
inhibition of LTP and LTD triggered by a subsequent stimulation. This effect was 
summarized as “the plasticity of synaptic plasticity” or, as mentioned above, as 
metaplasticity (Abraham and Bear, 1996). Since the beginning, metaplasticity was 
demonstrated to be mediated primarily by ionotropic and metabotropic glutamate 
receptors and their downstream cascades (Abraham and Tate, 1997). For example, 
aberrant metaplasticity seems to be involved in neurodegenerative disorders such 
as Alzheimer’s disease (AD). In AD, amyloid-β oligomers, one the main causes of 
the disease, reduces glutamate reuptake causing an increased activation of 
NMDARs, especially through GluN2B, possibly leading to excitotoxicity (Li et 
al., 2011). Moreover, GluN2B receptors have been linked also to Parkinson’s 
(Nash et al., 2004) and Huntington’s disease (Li et al., 2004).  
Besides synaptic and cellular metaplasticity, more recently metaplastic 
mechanisms have been hypothesized to underlie also behavioural conditions, 
conceptualized as “behavioural metaplasticity” and comprising long-lasting 
behavioural alteration resulting from metaplastic triggering events such as stress 
(Schmidt et al, 2013), enriched environment exposure or sensory deprivation 
(Abraham, 2008). Moreover, the increased synaptic plasticity mediated by drug 
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addiction has been suggested to be mediated possibly by metaplasticity-dependent 
LTP (Hulme et al., 2013). In fact, amphetamine and ethanol ease the induction of 
LTP through NMDARs in the dopaminergic neurons of the ventral tegmental area 
(Ahn et al., 2010; Bernier et al., 2011), while cocaine and methamphetamine 
induce long-term modulation of LTP magnitude in the CA1 area of hippocampus 
(Thompson et al., 2004; Swant et al., 2010). Moreover, cocaine exposure 
generates silent synapses in the nucleus accumbens, which then potentiate during 
abstinence (Hulme et al., 2013). Cocaine also enhanced excitatory strength in 
dopamine neurons of ventral tegmental area at 1, 7, 21 and even 90 days after the 
last self-administration session; interestingly, also sucrose self-administration was 
able to induce the same excitatory enhancement, though limited to 7 days after the 
last session (Chen et al., 2008). This last evidence suggests that even food 
addiction could depend on metaplastic neuromodulation. 
Acting through glutamatergic receptors for LTP and LTD modulation, it was 
hypothesized that metaplasticity could in turn influence also memory processing 
and the stages of consolidation and reconsolidation. A comprehensive and 
detailed review by Finnie and Nader in 2012 speculate on a number of cellular 
and molecular metaplastic mechanisms regulating memory destabilization and 
reconsolidation. One of the most emphasized metaplasticity-related process was 
the downregulation of NMDARs containing GluN2B or the increased 
GluN2A/GluN2B ratio after strong training, as the greater calcium transmission of 
GluN2B compared to GluN2A allows for synaptic destabilization mechanisms 
that must be blocked for long-term maintenance of relevant memory traces. 
Conversely, GluN2B is necessary for memory destabilization process and its 
trafficking from and to the post-synaptic membrane underlie activity-dependent 
remodeling of synaptic stability. Moreover, GluN2B can promote LTP by itself 
through a mechanism involving C-terminal cytoplasmic tail (Foster et al., 2010) 
or through the induction of CaMKII autophosphorylation, a mechanism required 
in many forms of long-lasting synaptic changes (Zhou et al., 2007).  
Another important molecular marker for plasticity, metaplasticity and memory 
processes are the calcium-permeable GluA1-containing AMPARs. Their 
membrane insertion after synaptic stimulation can lasts days after behavioural 
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experience; moreover, trafficking, stability and activity are regulated by PKA-
mediated phosphorylation, and PKA along with GluN2B and low voltage-gated 
calcium channels (LVGCCs) interact with GluA1 for destabilization regulation 
(Finnie and Nader, 2012).  
Finally, also metabotropic glutamate receptors seem to be involved in long-lasting 
plasticity mechanisms. Bortolotto et al. (2005) demonstrated that, after LTP, 
mGluR5 is fundamental for a molecular switch that render a subsequent LTP 
induction insensitive to mGluR antagonist MCPG (Bortolotto et al., 2005). 
Abraham in 2008, suggested that group I mGluRs (mGluR1 and mGluR5) could 
ease LTP induction by AMPARs and NMDARs trafficking and activity 
facilitation; moreover, mGluRs seem to be involved also in local synaptic protein 
synthesis through the stimulation of mTORC1 signaling cascade and its 
downstream effectors such as eF2, eF1α, CaMKII and phosphorylated-rpS6 
(rpS6P) (Abraham, 2008). More recently, Marton and colleagues in 2015 
proposed a metaplastic role for mGluR5 and its binding protein Homer1A, a 
plasticity-related immediate early gene, in long-lasting potentiation of striatal 
synapses, involving prior stimulation of D1Rs and acting through enhancement of 
NMDARs current, an effect hypothesized to underlie behavioural effect of 
cocaine self-administration. Moreover, interaction between mGluR5 and 
Homer1A has been related also to synaptic impairment in Fragile X syndrome, 
schizophrenia and age-related memory impairment (Marton et al., 2015). 
Chiamulera and colleagues in a recent review (2017) proposed to targeting 
mGluR5 as a therapeutic intervention for inhibition of appetitive memory 
reconsolidation (Chiamulera et al., 2017). 
In conclusion, metaplastic regulation of glutamate receptors and downstream 
cascade are potentially involved in a wide range of neurodegenerative and 
neuropsychiatric disorders, expanding the complexity of underlying mechanisms 
but also the possible targets that can be addressed for therapeutic purposes. 
However, despite the evidence presented above on metaplasticity involvement in 
substance and non-substance addiction as well as in memory processing, the 
influence of this high-order plasticity on these processes is far to be completely 
elucidated. Noteworthy, though in the last decade food addiction has received 
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increasing attention for the development of reliable therapeutic tools against 
obesity and obesity-related problems, the metaplasticity involvement in high 
palatable food memory consolidation, maintenance, reconsolidation or disruption 
remain to be fully investigated. 
 
1.8 Aims 
The present project was based on our previous experiments and literature 
evidence suggesting that it is possible to therapeutically address drug and non-
drug addiction affecting the reconsolidation process of the maladaptive memories 
underlying these pathologies. Nevertheless, among the scientific community there 
are still conflicting opinions in considering high palatable food addiction as a 
distinct pathology sharing mechanisms of drug addiction, even though other 
eating disorders such as bulimia nervosa (BN), food craving (FC) or obesity have 
been already included in the recent DSM-V (Zou et al., 2017). 
In light of these premises, this research has developed in two consecutive phases: 
1) To demonstrate that food addiction memory can undergo reactivation and 
reconsolidation, combining a typical behavioural protocol of instrumental 
conditioning with a new two-component molecular assay;  
2) To investigate whether the NMDA receptor blocker MK-801 given 24 h 
before retrieval could affect sucrose instrumental memory reconsolidation, 
following a protocol of administration known to induce metaplasticity 
(Buck et al., 2006).  
 
For the first part, we followed the behavioural protocol previously used in our 
laboratory for the study of nicotine instrumental memory reconsolidation 
(Tedesco et al., 2014a). After instrumental training for sucrose self-
administration, rats remained in their home cage for 14 days of abstinence, 
followed by operant memory retrieval (Ret group) or no-retrieval (No-Ret group) 
24 hours later. The day after, memory reinstatement was evaluated with an 
extinction test. Along with the behavioural protocol, we decided to characterize 
the pattern of expression of two markers of drug memory reconsolidation, i.e. 
Zif268 and the rpS6P, 2 hours after memory reactivation. The former, Zif268, a 
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well-known molecular marker of memory reconsolidation, is an immediate early 
gene involved in de-novo protein synthesis after memory reactivation (Veyrac et 
al., 2014). Conversely, rpS6P, part of the 40S ribosomal subunit, is a relatively 
new marker of memory reconsolidation, and it is known as a downstream 
effectors of mTORC1 signaling cascade, important for both appetitive and 
aversive memories due to its role in protein synthesis locally in the active 
synapses (Barak et al., 2013; Tedesco et al., 2014b). The protein levels of these 
two molecular markers were evaluated in four brain regions that are involved in 
the reward mesocorticolimbic circuitry, i.e. nucleus accumbens, hippocampus, 
central nucleus of amygdala and basolateral complex of amygdala. Moreover, in 
amygdala we evaluated also the protein level of two glutamatergic receptors 
characterized for their important role in memory destabilization and 
restabilization, that is GluN2B for the former (Milton et al., 2013) and GluA1 for 
the latter process (Monfils et al., 2009). 
 
For the second part, using the same behavioural protocol, we investigated 
whether the NMDA receptor blocker MK-801 was able to affect sucrose 
instrumental memory reconsolidation when given under a metaplasticity protocol. 
The PCP-like drug MK-801 has been already demonstrated to be effective in 
inhibiting memory reconsolidation in different paradigms when administrated 
close to retrieval session (Przybyslawski and Sara, 1997; Suzuki et al., 2004; Lee 
et al., 2006). However, only Buck and colleagues in 2006 demonstrated the 
metaplastic effect of MK-801. In fact, when administrated systemically in adult 
male rats, 4 mg/kg ip MK-801 was able to facilitate LTP induction in CA1-
subiculum synapses in ex-vivo hippocampal slices 24 h after injection (Buck et al., 
2006). Moreover, metaplastic effects has been shown also for another NMDARs 
blocker, i.e. ketamine. Ketamine, both intravenously and intraperitoneally, 
enhanced LTP in CA1 area of ex-vivo hippocampal slices 24 h after 
administration (Burgdorf et al., 2013; Graef et al., 2015). Moreover, 24 h post 
dosing, ketamine 10 mg/kg iv was able to induce antidepressant effects and to 
increase cell surface protein level of GluN2B and GluA1 in hippocampus and 
medial prefrontal cortex. In medial prefrontal cortex, ketamine increased also 
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GluN2B in a whole-cell lysate (Burgdorf et al., 2013). Zanos et al. (2016) finally, 
demonstrated that ketamine was able to increase GluA1 and GluA2 24 hours after 
treatment in mouse hippocampal, but not prefrontal, synaptoneurosomes (Zanos et 
al., 2016). These evidences indicate that NMDARs blockers possess a metaplastic 
action that eventually could have effects also on instrumental memory 
reconsolidation. Thus, following a behavioural protocol identical to the first part 
of the project, we conditioned rats to sucrose self-administration for 10 continuous 
days followed by 14 days of sucrose fasting. In this case, however, 24 hours 
before memory retrieval or no-retrieval we treated rats with either vehicle (saline 
solution) or MK-801 4 mg/kg ip. As before, after memory retrieval we evaluated 
memory reconsolidation with an extinction test 24 hours later.  
For the molecular assessment, we analyzed the level of Zif268 and rpS6P in 
nucleus accumbens shell, central nucleus of amygdala and basolateral complex of 
amygdala as well as GluA1, GluN2B and mGluR5 in the nucleus accumbens and 
amygdala 2 hours after memory reactivation. The effects were investigated in all 
the experimental groups, i.e. Veh/Ret, Veh/No-Ret, MK-801/Ret and MK-
801/No-Ret, in order to demonstrate that MK-801 administrated according to a 
metaplastic protocol can modulate key molecular markers for destabilization and 
restabilization, affecting reconsolidation of food instrumental memory. 
All the behavioural phases of our experiments were performed in eight Skinner 
boxes equipped with two levers, one active on the right and one inactive on the 
left, a food magazine between the levers with the food dispenser behind the 
frontal wall, and an house light on the back panel of the box (Figure 8). 
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Figure 8: A Skinner box used for instrumental conditioning, retrieval and memory 
reconsolidation tests. It is possible to note, on the frontal wall of the box, the 
inactive lever on the left (a), the active lever on the right (b), the food dispenser 
between the two levers and the magazine behind the frontal wall (c), and the 
house light on the back wall of the cage (hidden, d). Moreover, it is visible the 
grid floor and two CS lamps that were not used during the experiments located 
over the levers. All the Skinner boxes were placed inside a sound-isolated cubicle 
equipped with a fan providing ventilation and a background white noise (e).  
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2. MATERIALS AND METHODS 
2.1 Animals 
One hundred and fifty-eight male Sprague-Dawley rats (Charles River, Italy) 
were housed in pairs in temperature and humidity-controlled environment (19-
23°C, 60 ± 20 %) on a 12-h light/dark cycle, with light on at 7:30 pm. Rats were 
food restricted to maintain their body weight in the range of 250 ± 10 g (daily 
checked), and food (two to four pellets, 10-20 g/day) was made available after 
each experimental session. Water was available ad libitum, except during 
experimental sessions. Animals were trained or tested once daily during the dark 
phase of the light/dark cycle. All procedures were carried out in accordance with 
the U.K. Animals (Scientific Procedures) Act 1986 and associated guidelines, and 
with EU Directive 2010/63/EU for animal experiments. All procedures were 
approved by the ethical committee (OPBA) of the University of Verona and by 
the Ministry of Health (authorization n. 271/2013-B). All efforts were made to 
minimize animal suffering and to keep the lowest number of animals used. 
 
2.2 Apparatus 
Rats were trained and tested in operant chambers (Coulbourn Instruments, 
Lehigh Valley, Whitehall, PA, USA) encased in sound-insulated cubicles 
equipped with ventilation fans (Ugo Basile, Comerio, Italy). Each chamber was 
equipped with two levers, an active (right) and an inactive lever (left), 
symmetrically oriented laterally to the food magazine, on the frontal panel. Levels 
were located 2 cm and food magazine 1 cm above the grid floor. A 2-W white 
house light was located 26 cm above the food magazine and provided ambient 
illumination during the entire session duration of food-shaping, retrieval and 
reinstatement phases, and for the entire session except for time-out (TO) periods 
during training phase. Right lever press produced the delivery of a 45-mg sucrose 
food pellet (Bilaney Consultants Ltd, UK) with a fixed-ratio 1 (FR1) schedule of 
reinforcement during training. Left lever presses did not have consequences. 
Lever presses and pellet deliveries were recorded, as well schedule parameters 
and data acquisition were controlled, by Med-PC software (Med Associates Inc., 
St Albans, Vermont, USA). 
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2.3 Phase #1 
2.3.1 General Procedure 
The experimental protocols were designed according to the following phases 
(Figure 9, panel A): Phase I) training to sucrose self-administration (S/A), Phase 
II) forced abstinence in home cage and, Phase III) memory Retrieval (Ret) or No-
Retrieval (No-Ret). After these three subsequent phases, rats were divided in two 
groups: one group performed the reinstatement test in the training context 24 h 
and 7 d after Phase III, while animals in the second group were sacrificed for 
immunoblotting or immunohistochemical staining. During Phase III, rats were 
exposed to Ret or No-Ret session in the training context, i.e. Context A (AAA 
protocol) or in a novel context, i.e. Context B (ABA protocol). 
 
2.3.2 Lever press shaping and training to sucrose self-administration 
All rats were initially shaped to associate right lever presses with sucrose 
pellets as reinforcement. The schedule was an FR1 schedule, with the delivery of 
45-mg sucrose food pellets, no delivery time-out during the procedures and 
sessions lasted up to 100 reinforcements or 120 min. Once the criterium of 100 
reinforcements was reached, animals started training Phase I. During Phase I, 
right lever pressing delivered sucrose reinforcement with the same FR1, but with 
a 60-s time-out between two consecutive reinforcements, and the sessions lasted 
up to 12 reinforcements or 60 min. During time-out the right lever presses had no 
consequences, and the house light switched off. Left lever presses had no 
consequences for all the experimental period. After 10 continuous days of sucrose 
S/A training, rats remained 14 days in home cages for forced abstinence phase. 
 
2.3.3 Behavioural analysis: retrieval procedure and reinstatement tests 
After forced abstinence phase, rats were divided in two groups and exposed to 
a non-reinforced retrieval (Ret) or no-retrieval (No-Ret) session in the training 
context. During the Ret session, both the levers were presented and rats were 
allowed to press right active lever up to 20 times, with the house light on. Lever 
presses had no consequences. During the No-Ret session, no levers were 
presented and house light was off. During Ret or No-Ret session, animals spent a 
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similar amount of time in the training context (181±10 s; mean ± SEM). Two 
separate groups of rats were exposed to Ret or to No-Ret session in a novel 
context (Context B; operant conditioning chamber with 5-cm blank striped sheets 
on the walls and a 1-cm grid on the floor; Auber et al., 2014). Twenty-four hours 
after Ret or No-Ret all subjects were re-exposed for 60 min to the training context 
in the presence of levers, house light on and no time-out for a non-reinforced 
reinstatement test, to evaluate sucrose seeking behaviour. Lever presses had no 
consequences. Reinstatement test was replicated 7 d after retrieval Phase. All 
lever presses were recorded during Ret and reinstatement phases. 
 
2.3.4 Molecular analysis: retrieval procedure and brain extraction 
After forced abstinence phase, 4 separated groups of rats were exposed to Ret 
or No-Ret session, 2 groups in the training context and 2 groups in the novel 
context (Context B), as described in the previous section. Two hours after the first 
lever pressed during Ret or after the beginning of No-Ret session, all rats were 
sacrificed for Zif268 and rpS6P immunohistochemistry or GluN2B and GluA1 
western blot investigations.  
 
2.3.5 Immunohistochemistry 
Rats were anesthetized with 350mg/kg/2 mL ip chloral hydrate (Fluka, Italy), 
then transcardially perfused with heparin 100 UI/L (Sigma–Aldrich, Milan, Italy) 
in saline solution and paraformaldehyde (PFA) 4 % in phosphate buffered saline 
solution (PBS). Brains were removed and post-fixed for 2 h at 4 °C into PFA 4 % 
in PBS, then washed 3 times with PBS and put in sucrose 30 % in PBS as 
cryoprotective for 48 h. Free-floating sections (40 μm) containing nucleus 
accumbens shell (NacS) (corresponding to a bregma +1.70 mm section from 
Paxinos and Watson, 1998); dorsal hippocampus (Hipp) (bregma -3.00 mm), 
central nucleus of amygdala (CeA) (bregma -1.88) and basolateral complex of the 
amygdala (BLA) (bregma -3.00 mm) were processed for Zif268 and rpS6P 
immunoreactivity. After washing in PBS, endogenous peroxidase was neutralized 
with hydrogen peroxide 0.75 % in PBS for 10 min. Sections were blocked with 
0.5 % Horse Serum (HS; BioWhittaker-Lonza, Basel, Switzerland) + 0.5 % Triton 
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X-100 (Sigma-Aldrich, Milan, Italy) in PBS wash solution, and then incubated 
overnight at 4 °C with anti-Zif268 (1:1000, Santa Cruz, rabbit polyclonal) or anti-
PSer235/236-rpS6 antibody (1:1000, Cell Signaling, rabbit polyclonal) in wash 
solution. After washes in wash solution, slices were incubated for 2 h at room 
temperature with anti-rabbit biotinylated antibody (1:1000, AmershamGE 
Healthcare Europe, Milan, Italy). Following washes in wash solution, and finally 
in PBS, tissue sections were visualized using VectaStain ABC kit (Vector 
Laboratories, Rome, Italy) and developed in DAB peroxidase substrate (Sigma-
Aldrich, Milan, Italy) for 3-4 min. Sections were mounted on gelatin-coated 
slides, dehydrated and then closed with Entellan (Merck-Millipore, Darmstadt, 
Germany). The sections were acquired using a light transmission microscope 
(Axioscope 2 Zeiss, Zeiss). Six images for each region (1 for each hemisphere, 3 
sections for each rat, that is 2 × 3 = 6 images/region/rat) were acquired by the 
connected video camera (Optikam B3) using a 10X objective (0.3 mm2). Counts 
of the number of neurons positive to Zif268 and rpS6P were carried out using the 
NIH software ‘Image-J’ (www.rsbweb.nih.gov) (Caffino et al., 2016). 
 
2.3.6 Western Blot 
Rats were anesthetized with 350 mg/kg/2 mL ip chloral hydrate (Fluka, Italy), 
then brains were removed, and 1-mm slices containing amygdalae (bregma -3.00 
mm) were dissected by using a 1-mm Coronal Brain Matrix (SouthPointe Surgical 
Supply, Florida, USA). Amygdalae were lysed in a tube containing 1 % sodium 
dodecyl sulfate (SDS). Total protein levels were quantified using the Pierce 
(Rockford, IL, USA) BCA (bicinchoninic acid) Protein Assay. Forty micrograms 
of proteins were resolved by electrophoresis on a 8 % SDS polyacrylamide gel 
and transferred onto nitrocellulose membranes using the transblot TURBO (Bio-
Rad, Hercules, CA, USA). Blots were probed overnight at 4 °C with the 
polyclonal rabbit anti-GluA1 or the monoclonal mouse anti-GluN2B antibody 
(Thermo Scientific, Rockford, IL USA) diluted 1:1000 in 5 % milk. 
Immunodetection was performed with the secondary antibody anti-rabbit or anti-
mouse (1:2000) (Amersham Biosciences, UK) conjugated to horseradish 
peroxidase. The reactive bands were detected using chemiluminescence 
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(ECLplus; Euroclone, Padova, Italy). Quantitative analysis was performed using 
the QuantityOne analysis software (Bio-Rad, Hercules, CA, USA) (Gerace et al., 
2014). 
 
2.3.7 Data Analysis 
For the behavioural experiments, the number of active lever presses (ALP) 
and inactive lever presses (ILP) during reinstatement tests were compared to 
assess the effect of Ret versus No-Ret. Two separate two-way analyses of 
variance (ANOVAs) with the factors Condition and Test day were carried out on 
the total number of ALP or ILP/60 min in the reinstatement sessions.  
For the immunohistochemistry experiments, intensity threshold, minimum and 
maximum cell size values were initially determined in an empirical fashion under 
blind conditions. The dependent variable for the immunohistochemistry 
experiments was the positive cell count/mm2 for Zif268 or rpS6P. 
Immunohistochemistry and western blot data, as mean ± SEM percentages of the 
No-Ret rats, were analyzed by an unpaired Student’s t-test. All analyses were 
performed using the GraphPad software package (Prism, version 4; GraphPad, 
San Diego, California, USA).  
 
2.4 Phase #2 
2.4.1 General Procedure 
A schematic diagram of the protocol design is shown in Figure 14, panel A. 
The experimental protocols were designed according to the following phases: 
Phase I, training to sucrose pellets self-administration (S/A); Phase II, forced 
abstinence in home cage with M-K-801 or vehicle treatment 24 h before Phase III; 
and Phase III, memory Retrieval (Ret) or No- Retrieval (No-Ret) in the training 
context. After the three phases, rats were divided in two groups: one group 
performed the Reinstatement test in the training context 24 h after Phase III, while 
the animals in the second group were sacrificed for immunohistochemical staining 
2 h after Phase III. Two separate groups of rats were treated with MK-801 or 
vehicle and sacrificed 24 h later for immunoblotting assays. 
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2.4.2 Lever press shaping and training to sucrose self-administration  
All rats were initially shaped to associate right lever presses with sucrose 
pellets as reinforcement. The schedule was an FR1 schedule, with the delivery of 
45-mg sucrose food pellet, without time-out between consecutive reinforcement, 
and session lasted up to 100 reinforcements or 120 min. Once the criterion of 100 
reinforcements/session was reached, animals started training Phase I. During 
Phase I, right lever pressing delivered sucrose reinforcement with an FR1 
schedule but with a 60-s time-out between consecutive reinforcements, and 
sessions lasted up to 12 reinforcements or 60 min. During time-out, right lever 
presses had no consequences and the house light switched off. Left lever presses 
had no consequences for all the experimental sessions. After 10 continuous days 
of sucrose S/A training, rats remained 14 days in home cage for forced abstinence 
phase. 
 
2.4.3 Behavioural analysis: Retrieval procedure and Reinstatement tests 
During the last day of forced abstinence, 24 h before Phase III, rats were 
divided in two groups, one treated with saline solution (vehicle) 1 mL/kg ip and 
one treated with MK-801 4 mg/kg/mL ip. The day after, both groups were further 
divided into subgroups exposed to unreinforced Ret or No-Ret session in the 
training context. The four resulting subgroups were: Vehicle/Ret, Vehicle/No-Ret, 
MK-801/Ret and MK-801/No-Ret. During the Ret session, both levers were 
presented, and rats were allowed to press right active lever up to 20 times, with 
house light on; levers had no consequences during Ret. During the No-Ret 
session, no levers were presented and house light was off. During Ret or No-Ret 
session, animals spent a similar amount of time in the training context (185 ± 10 s; 
mean ± SEM). Twenty-four hours after Ret or No-Ret session all subjects were re-
exposed for 60 min to the training context in the presence of levers, house light on 
and no time-out for an unreinforced reinstatement test to evaluate sucrose seeking 
behaviour. Levers had no consequences during reinstatement. All lever presses 
were recorded during ret and reinstatement phases.  
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2.4.4 Molecular analysis: Retrieval procedure and brain extraction 
For the molecular analysis, four separated groups of rats were treated with 
vehicle or MK-801 and exposed to Ret or No-Ret session as described in the 
previous section. Then, 2 h after the first lever emitted during Ret or 2 h after the 
beginning of No-Ret session, all rats were sacrificed for Zif268 or rpS6P 
immunohistochemistry. 
 
2.4.5 Immunohistochemistry 
Rats were anesthetized with 350 mg/kg/2 mL ip chloral hydrate (Fluka, Italy), 
then transcardially perfused with heparin 100 UI/L (Sigma–Aldrich, Milan, Italy) 
in saline solution and paraformaldehyde (PFA) 4 % in 1X phosphate buffered 
saline solution (PBS). Brains were removed and post-fixed for 2 h at 4 °C into 
PFA 4 % in PBS, then washed 3 times with PBS and left in sucrose 30 % in PBS 
for cryoprotection for 48 h. Free-floating sections (40 μm) containing NacS 
(corresponding to a bregma +1.70 mm section from Paxinos and Watson, 1998), 
CeA (bregma -1.88) and BLA (bregma -3.00 mm) were processed for Zif268 or 
rpS6P immunoreactivity. After washing in PBS, endogenous peroxidase was 
neutralized with hydrogen peroxide 0.75 % in PBS for 10 min. Sections were 
blocked with 0.5 % Horse Serum (HS; BioWhittaker-Lonza, Basel, Switzerland) 
+ 0.5 % Triton X-100 (Sigma-Aldrich, Milan, Italy) in PBS wash solution, and 
then incubated overnight at 4 °C with anti-Zif268 (1:1000, Santa Cruz, rabbit 
polyclonal) or anti-PSer235/236-rpS6 antibody (1:1000, Cell Signaling, rabbit 
polyclonal) in wash solution. After washes in wash solution, slices were incubated 
for 2 h at room temperature with anti-rabbit biotinylated antibody (1:1000, 
Amersham GE Healthcare Europe, Milan, Italy). Following washes in wash 
solution, and finally in PBS, tissue sections were visualized using VectaStain 
ABC kit (Vector Laboratories, Rome, Italy) and developed in DAB peroxidase 
substrate (Sigma-Aldrich, Milan, Italy) for 3-4 min. Sections were mounted on 
gelatin-coated slides, dehydrated and then closed with Entellan (Merck-Millipore, 
Darmstadt, Germany). The sections were acquired using a light transmission 
microscope (Axioscope 2 Zeiss, Zeiss). Six images for each region (one for each 
hemisphere, 3 sections for each rat, that is 2 × 3 = 6 images/region/rat) were 
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acquired by the connected video camera (Optikam B3) using a 10X objective (0.3 
mm2). Counts of the number of neurons positive to Zif268 and rpS6P were 
carried out using the NIH software ‘Image-J’ (www.rsbweb.nih.gov) (Caffino et 
al., 2016). 
 
2.4.6 Pharmacological effects and western blot assays. 
To elucidate the metaplastic effects of MK-801 on the level of glutamate 
receptors, two separated groups of 5 rats/group were treated with MK-801 4 
mg/kg/mL ip or vehicle 1 mL/kg ip and 24 h later were anesthetized with 350 
mg/kg/2 mL ip chloral hydrate (Fluka, Italy) and sacrificed. Then, brains were 
removed and 1-mm fresh tissue slices containing nuclei accumbens (+1.70 mm) 
and amygdalae (bregma -3.00 mm) were dissected by using a 1-mm Coronal 
Brain Matrix (SouthPointe Surgical Supply, Florida, USA). After dissection of 
brain areas, proteins of post-synaptic density and extra-synaptic fraction were 
analyzed as described in Caffino et al. (2017) with minor modifications. Briefly, 
nuclei accumbens and amygdalae were homogenized in a teflon-glass potter in 
cold 0.32 M sucrose buffer pH 7.4 containing 1 mM HEPES, 1 mM MgCl2, 1 
mM NaHCO3 and 0.1 mM PMSF, in presence of commercial cocktails of protease 
(Roche, Monza, Italy) and phosphatase (Sigma-Aldrich, Milan, Italy). Each 
homogenate was centrifuged at 800 g for 5 min; the obtained supernatant was then 
centrifuged at 13000 g for 15 min obtaining a pellet. This pellet was re-suspended 
in buffer containing 75 mM KCl and 1% Triton X-100 and centrifuged at 100000 
g for 1 h. The resulting supernatant, referred as Triton X-100 soluble fraction 
(TSF, extra-synaptic fraction), was stored at -20°C; the pellet, referred as PSD or 
Triton X-100 insoluble fraction (TIF, post synaptic density), was homogenized in 
a glass–glass potter in 20 mM HEPES, protease and phosphatase inhibitors and 
stored at -20°C in presence of glycerol 30%. Total proteins have been measured in 
the TIF and TSF fractions according to the Bradford Protein Assay procedure 
(Bio-Rad, Milan, Italy), using bovine serum albumin as calibration standard. 
Equal amounts of proteins of the TIF fraction (8 μg) and of TSF fraction (15 μg) 
were run on a sodium dodecyl sulfate - 8% polyacrylamide gel under reducing 
conditions and then electrophoretically transferred onto nitrocellulose membranes 
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(GE Healthcare, Milan, Italy). Blots were blocked 1 h at room temperature with 
10% non-fat dry milk in TBS + 0,1% Tween-20 buffer and then incubated with 
antibodies against the proteins of interest. The conditions of the primary 
antibodies were the following: anti-GluN2B (1:1000, Santa Cruz Biotechnology, 
USA), anti-GluA1 (1:1000, Neuromab, USA), anti-mGluR5 (1:1000, Millipore, 
Italy) and anti-β-Actin (1:10000, Sigma-Aldrich, Italy). Results were standardized 
using β-actin as the control protein, which was detected by evaluating the band 
density at 43 kDa. Immunocomplexes were visualized by chemiluminescence 
using the Chemidoc MP Imaging System (Bio-Rad Laboratories).  
 
2.4.7 Data Analysis 
For the behavioural experiment, the number of active lever presses (ALP) 
after 60-min reinstatement test from the four groups Veh/No-Ret, MK-801/No-
Ret, Veh/Ret, MK-801/Ret was analyzed as dependent variable to assess the 
effect of drug treatment on retrieval condition. Two-way analysis of variance 
(ANOVA) with factors Treatment (Vehicle, MK-801) and Retrieval (Ret, No-Ret) 
was carried out on the total number of ALP after the reinstatement test. Two 
outlier subjects were discarded after outliers test. Fisher’s LSD post-hoc tests 
were used to carry out only meaningful comparisons between Veh/No-Ret vs. 
MK-801/No-Ret and Veh/Ret vs. MK-801/Ret. For the immunohistochemistry 
experiments, intensity threshold, minimum and maximum cell size values were 
initially determined in an empirical fashion under blind conditions. The dependent 
variable for the immunohistochemistry experiments was the positive cell 
count/mm2 for Zif268 or rpS6P. Two-way analyses of variance (ANOVAs) with 
the factors Treatment and Retrieval were carried out on mean ± SEM percentages 
of Zif268-positive cells/mm2 and rpS6P-positive cells/mm2 comparing the four 
different groups, with Vehicle/No-Ret as control group. Tukey’s post-hoc tests 
were used to carry out all multiple comparisons. For the western blots assays, 
mean ± SEM percentages of Vehicle group were analyzed by an unpaired 
Student’s t-test. All analyses were performed using the GraphPad software 
package (Prism, version 4; GraphPad, San Diego, California, USA). 
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3. RESULTS 
3.1 Phase #1  
The protocol of instrumental memory reconsolidation (Figure 9, panel A) 
showed no change of active lever presses/60 min after the reinstatement tests at 24 
h (115.7 + 18.9 vs. 94.2 - 9.4, mean ± SEM) and at 7 d (56.1 + 12.7 vs 41.4 - 4.3, 
mean ± SEM) for the Ret condition vs. the No-Ret condition (NS, Two-way 
ANOVA for main effect for factor Condition F[1,72] = 2.24; NS for interaction 
factors Condition and Test Day F[1,72] = 0.08) (Figure 9, panel B). 
Western blot analysis of total GluA1 protein level in the amygdala of rats exposed 
to Ret for instrumental memory showed a significantly higher level compared to 
rats under the No-Ret condition (+47 % GluA1/tubulin ratio vs. No-Ret; p = 0.03, 
Student’s t-test), suggesting that our experimental condition induces the retrieval 
of sucrose instrumental memory in amygdala (Fig. 10, panel a). 
 
 
Figure 9. Effect of retrieval on reinstatement performance. (A) Schematic diagram 
of the experimental protocol and groups. Boxes represent the different procedures 
used at the different phases of the study. Arrow represents time progression 
between consecutive phases. Cx A = sucrose self-administration training 
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(conditioning) context. (B) Effect of Retrieval (Ret) or No-Retrieval (No-Ret) 
session in the training context on memory reconsolidation. Ordinate represents 
number of lever presses (circle = active, ALP; triangle = inactive, ILP) 24 h or 7 d 
after Ret (solid circle, solid triangle) or No-Ret (open circle, open triangle). Data 
are expressed as mean ± SEM. N = 18-20 rats/group. 
 
 
Moreover, the analysis of total GluN2B protein level in the same brain area of rats 
exposed to Ret showed a significantly higher level compared to No-Ret (+43 % 
GluN2B/tubulin ratio vs. No-Ret; p = 0.004, Student’s t-test), suggesting that our 
memory retrieval is followed by memory destabilization process taking place in 
amygdala (Fig. 10, panel b). The marker of memory reactivation Zif268 showed a 
significantly higher expression in the Ret vs. No-Ret condition in the NAcS, CeA 
and BLA but not in Hipp, respectively 28.2 + 6.2 (p < 0.01, Student’s t-test), 
+30.7 + 5.4 (p < 0.001, Student’s t-test), +68.2 + 7.6 (p < 0.0001, Student’s t-test) 
and -11.0 + 7.7 (NS, Student’s t-test) (Fig. 11). Correlational analysis showed that 
the number of Zif268 positive cells in CA1 area of hippocampus positively 
correlated with counts in BLA (r = 0.89, p < 0.05; Pearson’s correlation) in the 
Ret but not in the No-Ret group (r = 0.71, p = 0.14; Pearson’s correlation) (data 
not shown). As a further confirmation of reconsolidation process occurrence, we 
assessed the phosphorylation level of protein translation marker rpS6 in the same 
areas. 
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Figure 10. Effect of retrieval on total GluA1-AMPARs and total GluN2B-
NMDARs in amygdala. In the upper part of the figure, representative 
immunoblots are shown for GluA1 (108 kDa, right) and GluN2B (180 kDa, left) 
proteins in the amygdala (Amy). (A-B) Quantification of the level of total GluA1-
AMPARs (A) and total GluN2B-NMDARs (B) 2 h after No-Retrieval (No-Ret; 
open column) or Retrieval (Ret; solid column) of sucrose instrumental memory in 
rats. Data are shown as the mean + SEM and are expressed as a percentage of the 
No-Ret rats. N=7 - 8 rats/group. *p < 0.05; **p < 0.01 vs. No-Ret (unpaired 
Student’s t-test). 
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Figure 11. Immunohistochemistry assessment of Zif268 expression. (A) 
Representative images of brain areas of interest, with circles indicating the 
microscopic frame of the region under analysis. (B) Representative images of 
microscope sections of nucleus accumbens shell (NAcS), hippocampus (Hipp), 
central nucleus of the amygdala (CeA) and basolateral complex of the amygdala 
(BLA) 2 h after No-Retrieval (No-Ret; open columns) or Retrieval (Ret; solid 
columns) of sucrose instrumental memory in rats. Zeiss Axioskop 2, objective 
10X. Scale bar, 100 μm. (C) Number of Zif268 expressing cells/mm2 in NAcS, 
Hipp, CeA and BLA 2 h after No-Ret or Ret. Data are shown as mean + SEM and 
are expressed as a percentage of the No-Ret control group. Three adjacent 
sections, both hemispheres, N = 4-6 rats/group. **p < 0.01; ***p < 0.001; ****p 
< 0.0001 vs. No-Ret (unpaired Student’s t-test).  
 
Phosphorylated rpS6 was significantly higher in the Ret vs. No-Ret condition in 
NAcS, CeA but not in BLA, respectively +20.7 + 6.9 (p < 0.05, Student’s t-test), 
+78.5 + 14.4 (p < 0.001, Student’s t-test) and -3.6 + 7.4 (NS, Student’s t-test). In 
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Hipp, phosphorylated rpS6 level was significantly reduced by the Ret exposure (-
22.1 + 6.9, p < 0.01, Student’s t-test) (Fig. 12).  
 
 
Figure 12. Immunohistochemistry assessment of rpS6P expression. (A) 
Representative images of brain areas of interest, with circles indicating the 
microscopic frame of the region under analysis. (B) Representative images of 
microscope sections of nucleus accumbens shell (NAcS), hippocampus (Hipp), 
central nucleus of the amygdala (CeA) and basolateral complex of the amygdala 
(BLA) 2 h after No-Retrieval (No-Ret; open columns) or Retrieval (Ret; solid 
columns) of sucrose instrumental memory in rats. Zeiss Axioskop 2, objective 
10X. Scale bar, 100 μm. (C) Number of rpS6P expressing cells/mm2 in NAcS, 
Hipp, CeA and BLA 2 h after No-Ret or Ret. Data are shown as mean + SEM and 
are expressed as a percentage of the No-Ret control group. Three adjacent 
sections, both hemispheres, N = 4-6 rats/group. *p < 0.05; **p < 0.01; ***p < 
0.001 vs. No-Ret (unpaired Student’s t-test). 
63 
 
In order to test for experimental conditioning context effect on instrumental 
memory reconsolidation in our protocol, we assessed the levels of Zif268 and 
rpsS6P in a separate group of rats where the memory reactivation was performed 
in a novel context (i.e., a modified conditioning box – context B - provided with 
the same levers). Under this ABA protocol, Zif268 expression pattern in the 
NAcS and in the amygdala was similar to the original AAA protocol (NAcS: 
+29.0 + 5.2, p < 0.001, Student’s t-test; CeA: +72.6 + 9.2 and BLA: +49.4 + 7.4, 
both at a significance level of p < 0.0001, Student’s t-test). Interestingly, Zif268 
was significantly increased in Hipp in Ret vs. No-Ret group, suggesting a context-
related effect (+37.7 + 8.0; p < 0.0001, Student’s t-test) (Fig. 13A), which 
however was not supported by any correlation between hippocampal CA1 and 
amygdalar nuclei. Phosphorylated rpS6 expression level, instead, was not changed 
in the NAcS, nor in the amygdalar nuclei CeA and BLA, and only slightly (-17.6 
+ 8.5, p < 0.05, Student’s t-test) decreased in Hipp (Fig. 13B). 
 
 
Figure 13. Immunohistochemistry assessment of Zif268 and rpS6P expression 
after retrieval in a novel context. (A) Number of Zif268 expressing cells/mm2 in 
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NAcS, Hipp, CeA and BLA 2 h after No-Retrieval (No-Ret) or Retrieval (Ret) of 
sucrose instrumental memory. (B) Number of rpS6P expressing cells/mm2 in 
NAcS, Hipp, CeA and BLA 2 h after No-Ret or Ret. Data are shown as mean + 
SEM and are expressed as a percentage of the No-Ret control group. Three 
adjacent sections, both hemispheres, N = 4 - 6 rats/group. *p < 0.05; ***p < 
0.001; ****p < 0.0001 vs. No-Ret (unpaired Student’s t-test). 
 
 
In summary, the reactivation of instrumental memory for sucrose under our AAA 
condition allows for a retrieval process (increased GluA1) and a destabilization 
process (increased GluN2B) in amygdala, which is confirmed by increased Zif268 
levels in amygdalar nuclei, and subsequent occurrence of reconsolidation process 
(rpS6P increasing in CeA, according to Barak et al., 2013). Although the control 
ABA condition showed a similar amygdalar Zif268 increase, a lack of rpS6P 
levels change did not however confirm the occurrence of the reconsolidation 
process. 
 
 
Table II. Summary table of the direction of effects of memory retrieval in sucrose 
self-administration training context (AAA protocol) or in the no-conditioning 
context (ABA protocol) on Zif268 and rpS6P. 
 AAA protocol ABA protocol 
 Zif268 rpS6P Zif268 rpS6P 
NAcS ↑ ↑ ↑ 0 
Hipp 0 ↓ ↑ ↓ 
CeA ↑ ↑ ↑ 0 
BLA ↑ 0 ↑ 0 
NAcS, nucleus accumbens shell; Hipp, dorsal hippocampus; CeA, central nucleus 
of the amygdala; BLA, basolateral complex of the amygdala. Symbols: ↑ = 
increase; ↓ = decrease; 0 = no change vs. No-Ret. 
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3.2 Phase #2 
Two-way ANOVA on reinstatement test showed a significant main effect of 
factor Treatment [(F (1, 41) = 5.7; p < 0.05] but not of Retrieval [F (1, 41) = 0.09; 
NS] and of Treatment x Retrieval interaction [F (1, 41) = 1.5; NS]. Fisher’s LSD 
post-hoc tests did not show significant differences between the two groups (94.3 ± 
9.3 vs. 82.2 ± 11.8; NS) when comparing ALP/60 mins between Veh/No-Ret and 
MK-801/No-Ret at Reinstatement. On the other hand, Fisher’s LSD post-hoc tests 
showed a significant decrease of active lever presses for MK-801/Ret compared to 
Veh/Ret group (103.9 ± 11.1 vs. 66.5 ± 7.7; p < 0.05) (Fig. 14B).  
 
 
Figure 14. (A) Schematic diagram of the experimental protocol and groups. Boxes 
represent the different procedures used at the different phases of the study. Arrow 
represents time progression between consecutive phases. Cx A = sucrose self-
administration training (conditioning) context. (B) Effect of Veh (open columns) 
or MK-801 (solid columns) treatment on Reinstatement performance when given 
24 h before Retrieval (Ret) or not (No-Ret). Ordinate represents number of lever 
presses after Reinstatement test. Data are expressed as mean + SEM. N = 9-12 
 
66 
 
rats/Veh groups, N=11-13 rats/MK-801 groups. *p < 0.05, Fisher’s LSD post-hoc 
tests. 
 
 
The analysis of the expression of Zif268 in the NAcS showed a significant main 
effect of factor Retrieval [two-way ANOVA, (F (1, 16) = 14.1; p < 0.01] and of 
Treatment x Retrieval interaction [F (1, 16) = 35.7; p < 0.0001] but not of 
Treatment [F (1, 16) = 0.6; NS]. Comparing the different groups, Tukey’s post-
hoc tests showed a significant percentual increase of Zif268 expression in the 
MK-801/No-Ret compared to Veh/No-Ret (+37.1 ± 10.0; p < 0.01), a significant 
decrease for MK-801/Ret compared to Veh/Ret (-48.2 ± 10.2; p < 0.01) and a 
significant increase for Veh/Ret compared to Veh/No-Ret (+69.4 ± 10.6; p < 
0.0001) (Fig. 15C). In the CeA, the analysis of Zif268 expression showed a 
significant main effect of factor Treatment [F (1, 16) = 20.3; p < 0.001] and of 
Treatment x Retrieval interaction [F (1, 16) = 96.6; p < 0.0001] but not of 
Retrieval [F (1, 16) = 0.3; NS]. Comparing the groups, Tukey’s post-hoc tests 
showed a significant increase of Zif268 in MK-801/No-Ret compared to Veh/No-
Ret (+85.4 ± 8.3; p < 0.0001) and a significant decrease of MK-801/Ret compared 
to Veh/Ret (-31.7 ± 8.5; p < 0.01). Moreover, Veh/Ret was significantly increased 
compared to Veh/No-Ret (+61.9 ± 8.8; p < 0.0001) and MK-801/Ret was 
significantly decreased compared to MK-801/No-Ret (-55.1 ± 8.0; p < 0.0001) 
(Fig. 15E). Similarly in the BLA, two-way ANOVA test showed a significant 
main effect of Treatment x Retrieval interaction [F (1, 16) = 90.0; p < 0.0001] but 
not of factor Treatment [F (1, 16) = 0.8; NS] nor of Retrieval [F (1, 16) = 1.6; 
NS]. Comparing the groups, Tukey’s post-hoc tests showed a significant increase 
of Zif268 in the MK-801/No-Ret compared to Veh/No-Ret (+90.4 ± 12.9; p < 
0.0001), and a significant decrease for MK-801/Ret compared to Veh/Ret (-74.9 ± 
11.7; p < 0.0001). Moreover, Veh/Ret was significantly increased compared to 
Veh/No-Ret (+71.7 ± 13.0; p < 0.001) MK-801/Ret was significantly decreased 
compared to MK-801/No-Ret (-93.5 ± 11.6; p < 0.0001) (Fig.15G). 
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Figure 15. Immunohistochemistry assessment of Zif268 expression 24 h after 
vehicle or MK-801 treatment, and 2 h after Ret or No-Ret session. (A) 
Representative images of brain areas of interest, with circles indicating the 
microscopic frame of the region under analysis. (B, D, F) Representative images 
of microscope sections of nucleus accumbens shell (NAcS, B), central nucleus of 
the amygdala (CeA, D) and basolateral complex of the amygdala (BLA, F) 24 h 
after vehicle (open columns) or MK-801 (solid columns) and 2 h after No-
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Retrieval (No-Ret) or Retrieval (Ret) session. Zeiss Axioskop 2, objective 10X. 
Scale bar, 100 μm. (C, E, G) Number of Zif268 positive cells/mm2 in NAcS, CeA 
and BLA 24 h after vehicle or MK-801 and 2 h after No-Ret or Ret. Data are 
shown as mean + SEM percentual values of Vehicle/No-Ret. Three adjacent 
sections, both hemispheres, N = 4-6 rats/group. **p < 0.01; ****p < 0.0001 
between treatments (same Ret or No-Ret), ###p < 0.001; ####p < 0.0001 vs. No-Ret 
within treatment, two-way ANOVA followed by Tukey’s post-hoc tests. 
 
 
To confirm the occurrence of memory reconsolidation process we assessed the 
phosphorylation level of protein translation marker rpS6 in the same areas. For the 
level of rpS6P in the NAcS, two-way ANOVA showed a significant main effect 
of Treatment x Retrieval interaction [F (1, 16) = 47.9; p < 0.0001] but not of 
factor Treatment [F (1, 16) = 0.01; NS] nor for Retrieval [(F (1, 16) = 1.4; NS]. 
Comparing the different conditions, Tukey’s post-hoc tests showed a significant 
increase of rpS6P level in the MK-801/No-Ret compared to Veh/No-Ret (+31.3 ± 
6.2; p < 0.001) and a significant decrease of MK-801/Ret compared to Veh/Ret (-
30.3 ± 6.4; p < 0.01). Moreover, Veh/Ret was significantly increased compared to 
Veh/No-Ret (+25.5 ± 6.6; p < 0.01) and MK-801/Ret was significantly decreased 
compared to MK-801/No-Ret (-36.13 ± 6.0; p < 0.0001) (Fig. 16C). In the CeA, 
two-way ANOVA showed a significant main effect of factor Retrieval [F (1, 16) 
=29.1; p < 0.0001] and of Treatment x Retrieval interaction [F (1, 16) = 50.0; p < 
0.0001] but not of Treatment [F (1, 16) = 2.9; NS]. Tukey’s post-hoc tests showed 
a significant increase of rpS6P level in the MK-801/No-Ret compared to Veh/No-
Ret (+48.4 ± 7.7; p < 0.0001), a significant decrease in the MK-801/Ret compared 
to Veh/Ret (-29.6 ± 7.9; p < 0.01) and a significant increase in the Veh/Ret 
compared to Veh/No-Ret (+68.7 ± 8.2; p < 0.0001) (Fig.16E). In BLA, two-way 
ANOVA showed no significant main effect of Treatment factor [F (1, 16) = 0.5; 
NS], of Retrieval [F (1, 16) = 0.2; NS] and of Treatment x Retrieval interaction [F 
(1, 16) = 1.3; NS]. Tukey’s post-hoc tests showed no significant differences 
among the four different experimental groups (Fig. 16G).  
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Figure 16. Immunohistochemistry assessment of rpS6P level 24 h after vehicle or 
MK-801 treatment and 2 h after Ret or No-Ret session. (A) Representative images 
of brain areas of interest, with circles indicating the microscopic frame of the 
region under analysis. (B, D, F) Representative images of microscope sections of 
nucleus accumbens shell (NAcS, B), central nucleus of the amygdala (CeA, D) 
and basolateral complex of the amygdala (BLA, F) 24 h after vehicle (open 
columns) or MK-801 (solid columns) and 2 h after No-Retrieval (No-Ret) or 
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Retrieval (Ret) session. Zeiss Axioskop 2, objective 10X. Scale bar, 100 μm. (C, 
E, G) Number of rpS6P positive cells/mm2 in NAcS, CeA and BLA 24 h after 
vehicle or MK-801 and 2 h after No-Ret or Ret. Data are shown as mean + SEM 
and are expressed as a percentual values of Vehicle/No-Ret. Three adjacent 
sections, both hemispheres, N = 4-6 rats/group. **p < 0.01; ***p < 0.001; ****p 
< 0.0001 between treatments (same Ret or No-Ret), ##p < 0.01; ####p < 0.0001 vs. 
No-Ret within treatment, two-way ANOVA followed by Tukey’s post-hoc tests. 
 
 
Western blot assays 24 h after MK-801 or Veh treatment in the post-synaptic 
density of NAc, the level of GluN2B and GluA1 after MK-801 was significantly 
increased compared to Veh (respectively +31.8 ± 4.9 and +47.4 ± 7.3; p < 0.001, 
Student’s t-test). Moreover, the analysis of the extra-synaptic fraction showed that 
MK-801 significantly increased mGluR5 level compared to Veh (+47.1 ± 7.8; p < 
0.001, Student’s t-test) (Fig.17B). In the post-synaptic density of the amygdala, 
the level of GluN2B after MK-801 was significantly increased compared to Veh 
(40.2 ± 6.2; p < 0.001, Student’s t-test), while the levels of GluA1 in the post-
synaptic density and of mGluR5 in the extra-synaptic fraction did not show 
significant difference compared to vehicle (respectively +3.8 ± 3.3 and -5.3 ± 9.6; 
NS, Student t-test) (Fig. 17D). 
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Figure 17. Effect of vehicle or MK-801 on GluN2B-containing NMDARs and 
GluA1-containing AMPARs in the post-synaptic density and on mGluR5 in the 
extra-synaptic fraction of nucleus accumbens and amygdala. (A, C) representative 
images of western blot bands with GluN2B (180 kDa, left) GluA1 (108 kDa, 
middle) and mGluR5 (130 kDa, right) compared to β-actin (43 kDa) as control. 
(B, D) quantification of GluN2B-NMDARs and GluA1-AMPARs level in the 
post-synaptic density and of mGluR5 in the extra-synaptic fraction 24 h after 
vehicle or MK-801 treatment in NAc (B) and amygdala (Amy) (D). Data are 
shown as the mean + SEM and are expressed as percentage of the vehicle. N=4-5 
rats/group. ***p < 0.001, unpaired Student’s t-test. 
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Table III. Summary table of the direction of effects of MK-801 or vehicle 
treatment on Zif268, rpS6P, GluN2B, GluA1 and mGluR5. 
 
 Nucleus Accumbens Shell Amygdala 
 Zif268 
 No-Ret Ret No-Ret Ret 
Vehicle 0 ↑ 0 ↑ 
MK-801 ↑ ↑ ↑  
 rpS6P 
Vehicle 0 ↑ 0* ↑* 
MK-801 ↑  ↑* ↑* 
     
 Nucleus Accumbens  Amygdala 
 GluN2B 
MK-801  
vs Vehicle 
↑ ↑ 
 GluA1 
MK-801  
vs Vehicle 
↑ 0 
 mGluR5 
MK-801  
vs Vehicle 
↑ 0 
Symbols: ↑ = increase; ↓ = decrease; 0 = no change. * = in central nucleus of 
amygdala only. 
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4. DISCUSSION 
In this project, we have investigated sucrose instrumental memory 
reconsolidation and whether this process could be affected applying a 
pharmacological treatment known to induce metaplasticity before the reactivation 
of the memory trace. The investigation was performed combining a behavioural 
protocol (developed and validated in our laboratory and shown to be able to 
evidentiate nicotine instrumental memory reconsolidation; Tedesco et al., 2014a) 
with a two-component molecular assay focusing on the protein level of Zif268 
and rpS6P as markers of memory reactivation and reconsolidation in brain areas 
relevant for addiction, such as nucleus accumbens shell, central nucleus of 
amygdala and basolateral complex of amygdala. Moreover, the molecular assay 
was extended to GluN2B, GluA1 and also to mGluR5 in order to analyze the 
protein level of key glutamatergic receptors for both memory modulation and 
long-lasting synaptic remodeling in the nucleus accumbens and amygdala. The 
results can be summarized as follows: i) sucrose instrumental memory 
reconsolidation was demonstrated using the Zif268/rpS6P two-component 
molecular markers, even though behavioural test did not shown any significant 
results; ii) MK-801 intraperitoneal injection exerted a long-lasting metaplastic 
effect that, followed by memory reactivation, resulted in a significant inhibition of 
instrumental responding at the behavioural test iii) the molecular evidence 
supported the behavioural result, demonstrating that the levels Zif268, rpS6P as 
well as GluN2B, GluA1 and mGluR5 were affected by MK-801 before memory 
reactivation.  
 
In the first part of the project, we showed that a protocol of instrumental 
memory reactivation induced memory retrieval and reconsolidation, as 
demonstrated by the increased expression of the transcription factor Zif268 and 
further confirmed by rpS6P, marker of mRNA translation and protein synthesis in 
active synapses. These molecular changes occurred in brain areas involved in 
appetitive memory retrieval and reconsolidation, i.e. nucleus accumbens shell, 
central nucleus of amygdala, and basolateral complex of amygdala. Molecular 
experiments performed to control for context effect showed that exposure to a 
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novel context during reactivation did not induce instrumental memory retrieval, as 
shown by the lack of rpS6P modulation despite Zif268 increase, and confirmed 
the specificity of increased rpS6P level in the nucleus accumbens shell and central 
nucleus of amygdala. The Zif268/rpS6P molecular markers appears to be reliable 
assays for instrumental retrieval and reconsolidation investigation, despite no 
behavioural changes during the reinstatement test. In fact, reconsolidation 
occurrence as an increased behavioural response has been rarely seen (Fuchs et 
al., 2009; Lasseter et al., 2011; Flavell and Lee, 2013; Tedesco et al., 2014a), and, 
as mentioned in the Introduction, reconsolidation occurrence is typically 
demonstrated through its inhibition (Lee, 2009). 
The behavioural protocol used in the present study is similar to the one we 
previously used for retrieval and reconsolidation of nicotine self-administration. 
In that study, rats were trained to lever press for nicotine reinforcement without 
association to any discrete cue, as light or tone (Tedesco et al., 2014a). Similarly, 
in the present study we trained rats to lever press for sucrose pellets self-
administration in a fixed number of consecutive trials, during which a limited 
amount of reinforcements per trials were available. After two weeks of forced 
sucrose fasting, reactivation of instrumental memory was induced by twenty non-
reinforced lever presses, as previously shown for nicotine by Tedesco et al. 
(2014). However, differently from that study, we did not observe any significant 
increase of responding in retrieval vs. no-retrieval group at the reinstatement tests 
performed twenty-four hours and one week later. NMDARs antagonists such as 
MK-801, given after retrieval, have been shown to inhibit the reconsolidation of 
appetitive drug-associated memory in different Pavlovian conditioning paradigms 
in rats (Sorg, 2012). More importantly, as reported in paragraph 1.6.4, 
destabilization and reconsolidation of instrumental response for palatable food is 
possible – as confirmed by inhibited conditioned response for sucrose after 
blockade of protein synthesis (Mierzejewski et al., 2008) or NMDA receptors 
(Exton-McGuinness et al., 2014). In the latter, authors showed that instrumental 
memory reconsolidation occurred only when reactivated under a reinforced VR20 
schedule of reinforcement, but not under a reinforced FR20 or non-reinforced 
(like our protocol) schedules. Moreover, Exton-McGuiness and Lee in 2015 
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confirmed instrumental memory reconsolidation also in weakly trained animals 
reactivated with a reinforced VR5, but not FR1 or non-reinforced session. Their 
findings were different from the earliest studies of Hernandez and Kelley (2004) 
and Mierzejewski et al. (2009) reporting no reconsolidation of instrumental 
memory after 15-day of sucrose S/A. However, both these studies used protein 
synthesis inhibitor, i.e. anisomycin the former and cycloheximide the latter, 
immediately after S/A. Considering that long-lasting training could have induced 
asymptotic learning that was reported as protein-synthesis independent 
(Rodriguez-Ortiz et al., 2005), it is conceivable to hypothesize that PSIs 
administrated after a training session are ineffective in disrupting memory 
reconsolidation. Moreover, in both the studies they used a training session 
including CS and US as memory retrieval session, thus lacking the novelty 
component that has been recently proposed as important for memory reactivation. 
In fact, the studies of from JLC Lee’s Lab mentioned above suggested that the use 
of a reinforced variable-ratio (VR) schedule, but not of a Fixed-ratio (FR) or a 
non-reinforced schedule, owns those salient features of unpredictability that 
contribute to a prediction error signal and therefore to memory destabilization 
(Exton-McGuinness et al., 2015). Recent studies showed that a predictability 
change of the unconditioned stimulus appears to be associated with Pavlovian 
memory destabilization (Díaz-Mataix et al., 2013; Sevenster et al., 2013). In the 
case of Pavlovian memories, a VR schedule may provide a more reliable method 
of generating prediction error (Merlo et al., 2014; Piñeyro et al., 2014). According 
to the ‘prediction error’ hypothesis, Exton-McGuinness et al. (2015) suggested 
that our procedure in Tedesco et al. (2014a) might not induce reconsolidation of 
the instrumental component of memory. However, as they admitted in a sequent 
statement, it is not even possible to exclude that the non-reinforced FR-20 used in 
our experiments represent a sufficient change from training conditions able to 
trigger an error in prediction (Exton- McGuinness et al., 2014). 
Another factor that should be considered is the role of the conditioning training 
context. Although there were no significant differences in responding at 
reinstatement tests between Ret and No-Ret groups under both AAA and ABA 
protocols (training, retrieval and tests in the conditioning context A for the former, 
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training in context A, retrieval in a novel context B and tests in context A for the 
latter), the expression level of Zif268 and rpS6P in the brain areas of our interest 
were different, suggesting the occurrence of memory reconsolidation under AAA 
but not ABA conditions. This context control experiment further suggests a 
potential role of the conditioning training context itself (i.e., Context A) as an 
occasion-setter, i.e. contributing but not sufficient per sé to memory retrieval 
(Bouton, 1993, 2004). In support of this hypothesis, Fuchs et al. have provided 
evidence about context-dependent reconsolidation of appetitive memories (Fuchs 
et al., 2009) and Flavell et al. (2011) demonstrated that the simple exposure to the 
training context was able to reactivate instrumental memory, as a following 
extinction session affected memory reconsolidation similarly to CS-exposure 
retrieval (Flavell et al., 2011).  
The molecular assessment in key brain areas after instrumental memory 
reactivation was confirmed by the occurrence of processes such as retrieval and 
destabilization, as shown by increased expression in amygdala of GluA1 receptors 
for the former, and GluN2B receptors for the latter. GluN2B receptors have been 
shown to play a central role in the molecular processes that allow the 
destabilization of the memory trace (Finnie and Nader, 2012), whereas GluA1 
receptors have been reported to be implicated in memory retrieval (Monfils et al., 
2009; Clem and Huganir, 2010). Moreover, the antagonism of GluN2B blocks 
destabilization and the possibility for memory to undergo retrieval and 
reconsolidation (Ben Mamou et al., 2006; Milton et al., 2008a, 2012, 2013). 
Transcription factor Zif268 has been widely used as a marker of memory 
reactivation and reconsolidation (Lee et al., 2004; Lee, 2008; Besnard et al., 
2013), with its inhibition leading to reconsolidation blockade (Veyrac et al., 
2014). In our study we observed a significantly higher expression level of Zif268 
in basolateral complex of amygdala, as well as in other areas that are relevant for 
the reactivation of appetitive memory such as central nucleus of amygdala (Barak 
et al., 2013) and nucleus accumbens shell (Exton-McGuinness et al., 2015), 
supporting the reactivation of instrumental memory. Significant Zif268 increase in 
central amygdala but not in dorsal hippocampus further suggests a role of 
contextual information, without apparently involving a hippocampal-related 
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spatial information component. Interestingly, the role of central amygdala-related 
contextual value is confirmed by an increased level of rpS6P in this area, as 
originally showed by Barak et al. (2013) for alcohol memory reconsolidation. The 
role of the amygdala-dorsal hippocampus connections in memory reconsolidation 
has been investigated by Rita Fuchs’s group showing that dorsal hippocampus is 
activated in response to amygdala activation, thus it does not play a necessary role 
by itself (Ramirez et al., 2009; Lasseter et al., 2011). Noteworthy, hippocampal 
Zif268 is significantly increased after retrieval vs. no-retrieval under ABA 
conditions, presumably due to the novelty features of the context B (Bozon et al., 
2003). 
Enhanced glutamatergic transmission through glutamate AMPA and NMDA 
receptors affects protein translation such as Akt and ERK1/2 (Gong et al., 2006): 
Akt activates phosphorylate mTOR and downstream rpS6 (Ferrari et al., 1991; 
Ruvinsky and Meyuhas, 2006), whereas ERK1/2 pathway induces rpS6 
phosphorylation via p70S6K (Bessard et al., 2007) and p90S6K (Roux et al., 
2007). This broad regulation of rpS6 phosphorylation makes it a sort of 
‘convergent’ marker of those synaptic processes leading to rapid regulation of 
mRNA translation and de novo protein synthesis (for a review see Biever et al., 
2015). The increased level of rpS6P in amygdala is a confirmation of the validity 
of this marker for the molecular assessment of memory reconsolidation (Barak et 
al., 2013; Tedesco et al., 2014b). Moreover, our study shows that an increased 
rpS6 phosphorylation in the nucleus accumbens shell indicates a specific increase 
of mRNA translation in brain nuclei relevant for appetitive memory. In the 
context-control condition ABA, rpS6P level was not different between retrieval 
and no-retrieval in central amygdala and nucleus accumbens shell, further 
confirming the specificity of our protocol of instrumental memory reactivation 
and reconsolidation under the AAA condition. On the other hand, we cannot 
currently explain rpS6P decrease in dorsal hippocampus; we exclude hippocampal 
rpS6P reduction due to different diurnal oscillation in the retrieval vs. the no-
retrieval groups (Saraf et al., 2014). 
As summarized in Table II, our findings suggest that the associated Zif268 and 
rpS6P expression assessment may be a molecular confirmation of transcription 
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(Zif268) and translation (rpS6P) activation respectively, with the latter 
specifically expressed by the training context condition AAA. We therefore 
proposed this dual-component molecular assessment as a reliable method, 
alternative to indirect (i.e., through inhibition) analysis of memory reconsolidation 
occurrence. In conclusion, this molecular approach confirmed that our protocol is 
able to reactivate instrumental appetitive memory and to trigger reconsolidation 
for sucrose. Together with our previous study on reconsolidation of nicotine 
instrumental responding (Tedesco et al., 2014a) and those from others (Exton-
McGuinness et al., 2014; 2015), we suggest that also instrumental appetitive 
memory can undergo reactivation and reconsolidation. 
 
In the second part of the project, we showed that MK-801 given 24 hours 
before instrumental memory reactivation (-24h MK-801/Retrieval) significantly 
inhibited the reinstatement of conditioned responding for sucrose. This effect was 
associated to a significant decrease of Zif268 in nucleus accumbens shell, central 
amygdala and basolateral amygdala, compared to Zif268 level in the same brain 
areas after vehicle followed by retrieval session. However, MK-801 per sé 
increased Zif268 level in the same brain areas after No-Retrieval compared to 
Vehicle/No-Retrieval group, similarly to the effect observed after the 
Vehicle/Retrieval session. Therefore, the behavioural inhibitory effect observed in 
the MK-801/Retrieval group could be specifically associated only in amygdala to 
a significant inhibition of increased Zif268 levels induced by either 
Vehicle/Retrieval or by MK-801/No-Retrieval. 
The increased phosphorylation of rpS6P in the nucleus accumbens shell and 
central amygdala in the Vehicle/Retrieval group was reduced in the MK-
801/Retrieval group. However, MK-801 per sé also increased phosphorylation of 
rpS6 in the same brain areas in the MK-801/No-Retrieval compared to 
Vehicle/No-Retrieval group. It therefore appears that the MK-801/Retrieval 
condition (associated to the behavioural inhibition of reinstatement) specifically 
inhibited increased rpS6 phosphorylation induced by either Vehicle/Retrieval or 
by MK-801/No-Retrieval only in the nucleus accumbens shell. On a separate 
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experiment, we have also shown that MK-801 increased GluN2B, GluA1 and 
mGluR5 expression level in nucleus accumbens and GluN2B in amygdala. 
The behavioural inhibitory effect of -24h MK-801 on instrumental memory 
reconsolidation when given under a dosing protocol known to induce metaplastic 
effects (Buck et al., 2006; Zorumski and Izumi, 2012) appears to be necessarily 
associated to the procedure of the instrumental memory reactivation. This 
behavioural effect is specifically related to the inhibition of retrieval and 
reconsolidation markers Zif268 in both central and basolateral amygdala, and 
rpS6 phosphorylation in nucleus accumbens shell. The former molecular 
correlation is interestingly linked to -24h MK-801-induced increase of GluN2B 
synaptic levels in amygdala, a proposed metaplasticity marker of memory 
destabilization (Finnie and Nader, 2012). The effect on rpS6 phosphorylation in 
the nucleus accumbens shell is on the other hand associated to -24h MK-801-
induced increase of GluN2B, GluA1 and mGluR5 levels in nucleus accumbens. 
These metaplastic molecular changes might have facilitated destabilization, 
respectively in amygdala (GluN2B) and/or in nucleus accumbens (GluN2B, 
GluA1 and mGluR5), allowing inhibition of the memory reconsolidation and then, 
inhibition of the reinstatement of instrumental responding.  
We hypothesize that the metaplasticity mechanisms triggered by -24h MK-801 
might have raised a direction change in the synaptic activation induced by the 
behavioural manipulation aimed to induce memory reactivation. The question 
however is: which is the process that after -24h MK-801-primed metaplastic 
condition and under memory retrieval allowed the inhibition of memory 
reconsolidation in the MK-801/Retrieval group? Or, as an alternative 
interpretation, is it possible that a process of extinction took place rather than 
reconsolidation inhibition? Indeed, it could be speculated that the facilitation of 
memory destabilization (as supported for instance by the metaplastic increase of 
GluN2B in amygdala) which should allow memory reconsolidation occurrence, it 
had on the other hand set in turn in the -24h MK-801/Retrieval group the 
conditions for a retrieval-contingent process of extinction rather than 
reconsolidation. The competition between reconsolidation and extinction 
processes during memory retrieval is a phenomenon that has been described for 
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reactivation sessions of intermediate length, which is neither short enough for 
reconsolidation nor too long for extinction, as reported for non-reinforced 
reactivation procedures (Flavell and Lee, 2013; Merlo et al., 2014). The 
metaplastic synaptic pattern changes induced by -24h MK-801 paired to the 
Retrieval, but not when paired to the No-Retrieval, condition may have shifted the 
balance between reconsolidation and extinction by favoring the acquisition of 
extinction as the predominant process, in this case as a new form of learning 
where responding was not associated to reinforcement delivery. It could be 
hypothesized that the parameters characterizing our retrieval session were close 
enough to the boundary conditions depicted in the paragraph 1.6.2, so that the 
metaplastic effects of MK-801 has been sufficient to shift the balance between 
reconsolidation and extinction occurrence towards the latter. 
The decrease of Zif268 expression levels in amygdala in the -24h MK-
801/Retrieval group may be interpreted as the possible molecular correlate of this 
shift to extinction. The transcription factor Zif268 has been widely used as a 
marker of memory reactivation and reconsolidation (Besnard et al., 2013; Lee, 
2008; Lee et al., 2004). In the first part of the project, we showed that increased 
levels of Zif268 in amygdala and nucleus accumbens shell were correlated to 
memory reactivation and reconsolidation. Although Zif268 inhibition leads to 
reconsolidation blockade (Veyrac et al., 2014), however we cannot exclude that 
decreased Zif268 levels might also induced extinction facilitation. Trent et al. 
(2015) recently showed that the expression of immediate early genes (including 
Zif268) constrained extinction occurrence during the early phase of contextual 
memory reactivation; in fact knockdown of Zif268 levels during a short recall 
favored extinction occurrence rather than reconsolidation inhibition, whereas 
during a longer recall, changes in Zif268 had not effect. We could therefore 
speculate that with our reactivation parameters (similar to a short recall) a 
decrease of Zif268 levels in amygdala in the -24h MK-801/Retrieval group may 
have induced extinction.  
Previous studies showed that increased rpS6 phosphorylation is correlated to 
memory reconsolidation (Barak et al., 2013; Tedesco et al., 2014b) and to 
reinforcing drug effect (Tedesco et al., 2013; Zanda et al., 2017). Due to the broad 
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regulation characterizing the phosphorylation of rpS6 (Ruvinsky and Meyuhas, 
2006; Bessard et al., 2007; Roux et al., 2007), it cannot be possible to speculate 
which mechanism brought to reduction of the rpS6 phosphorylation even though a 
different balancing between signaling cascade predominance could be a potential 
cause.  
An increase of GluN2B has been shown to facilitate destabilization (Ben Mamou 
et al., 2006; Milton et al., 2013; Wang et al., 2009). GluA1 instead has been 
demonstrated as important for memory retrieval (Clem and Huganir, 2010; 
Monfils et al., 2009) in a way dissociable from its role in destabilization (Milton 
et al., 2013), suggesting that these two processes may occur in parallel through 
two separate glutamatergic networks in amygdala (Lee and Flavell, 2014; Milton 
et al., 2013). Although there is a limited literature on Group I metabotropic 
glutamate receptors and memory reconsolidation (Gieros et al., 2012; Salinska, 
2006), we have recently proposed that Group I subtype mGluR5 is involved in 
memory reconsolidation and mGluR5 antagonism may act as inhibitor based on 
the role played by the receptors in glutamatergic transmission modulation 
(Chiamulera et al., 2017). Moreover, glutamate receptors GluN2B, GluA1 and 
mGluR5 have been linked to different forms of metaplasticity, as reported in 
paragraph 1.7. Thus, in accordance to suggestions by Finnie and Nader (2012), the 
increased expression of glutamate receptors after -24h MK-801 may mediate the 
effects of increased glutamate release that occur when memory is reactivated. 
GluN2B levels appears to be important both in amygdala and nucleus accumbens 
not only for the mediation of metaplasticity and the regulation of memory 
destabilization, but also as an ‘NMDARs dependency’ factor that could explain 
the hypothetical “reconsolidation-to-extinction shift” suggested before, in 
accordance to the NMDARs-dependent reconsolidation-to-extinction transition in 
fear memory (Merlo et al., 2014). 
 
In conclusion, our findings showed that NMDARs antagonism-induced 
metaplastic changes by MK-801 affected the retrieval of appetitive instrumental 
memories – either via reconsolidation inhibition or extinction facilitation – and 
the reinstatement of conditioned responding for sucrose. These data suggest that 
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pharmacological modulation of NMDARs given under a ‘metaplastic dose-
regimen’ may be relevant for learning and memory at a behavioural level. 
However, the overall project has some limitations. First of all, as suggested above, 
we were not able to observe a significant increase in retrieval vs. no-retrieval 
group during reinstatement test in the first part of the project. In fact, even in 
presence of a trend of increase 24 hours after reactivation, the difference was not 
statistically significant. It should be taken into account, however, that only few 
studies were able to induce a significant increase in responding at test, and most 
of the studies demonstrated reconsolidation through its inhibition. Moreover, the 
rats of the no-retrieval control group were exposed to conditioning context 
without levers, in contrast to the retrieval group, where rats were exposed to 
conditioning context equipped with levers. Considering previous evidence by 
Fuchs et al. (2009), Flavell et al. (2011) and our control experiments (ABA 
protocol) depicting the conditioning context as an occasion-setter for memory 
reactivation, it could be consider to test our retrieval condition compared to a no-
retrieval group were rats have been exposed only to their home-cage after saline 
treatment. 
Moreover, we demonstrated memory reconsolidation through the Zif268/rpS6P 
molecular assay comparing the levels of the two reactivation and reconsolidation 
markers 2 hours after retrieval vs. no-retrieval sessions. To improve the reliability 
of this method it could be helpful to selectively block Zif268 increase and/or rpS6 
phosphorylation in order to see whether these treatments could modulate 
reconsolidation occurrence. The same selective inhibition toward glutamate 
receptors could further highlight their fundamental role in memory reactivation 
and reconsolidation process.  
Another important limitation of our project is the MK-801 time of treatment. In 
fact, usually memory is inhibited through the injection of NMDARs antagonists or 
PSIs closely to the reactivation session. Here, instead, we injected MK-801 24 
hours before memory reactivation. The only evidence supporting a long-lasting 
effect of MK-801 is from Buck et al. (2006). However, in that study authors 
analyzed the facilitation of long-term potentiation in hippocampal synapses, while 
in our study we extended the interest to memory reconsolidation and to different 
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molecular markers related to reconsolidation and metaplasticity. Thus, a possible 
experiment could target memory reconsolidation with an MK-801 injection with 
dose and timing similar to previous studies (Lee and Everitt, 2008b; Tedesco et 
al., 2014a), in order to demonstrate that MK-801 is effective in inhibiting pure 
sucrose instrumental memory reconsolidation also in our experimental condition. 
Moreover, another aspect to be elucidated is the pharmacological effect of MK-
801 on the metaplasticity and reconsolidation markers of our interest. We know 
that MK-801 half-life is 2 hours (Vezzani et al., 1989), so it is possible to exclude 
a direct effect of the drug on these markers. Nevertheless, a temporal 
characterization for the molecular mechanisms triggered by MK-801 and 
occurring during the 24 hours temporal period before memory retrieval is still 
lacking and should be investigated. Besides, further investigations should focalize 
the attention on synaptic and neuronal network activity changes. In-vivo 
electrophysiological recording (EEG) would allow studying in real-time the 
functional neuroanatomical connectivity during the procedure of instrumental 
memory reactivation and then during reinstatement test, without the 
methodological limitations of ex-vivo molecular post-retrieval assessment. 
Furthermore, in-vivo EEG recording could permit to extend our analysis also to 
the other phases of instrumental memory, such as conditioning and long-term 
memory tests, not replacing but supporting the ex-vivo evidence providing the 
possibility to identify electrophysiological correlates to the already known 
molecular markers of the different stages of memory processing. However, to 
assert with confidence that we are facing metaplastic effects on nucleus 
accumbens and amygdala – and possibly on other memory-related brain areas – 
after MK-801 systemic injection, an electrophysiological study on cultured brain 
slices, as performed in Buck et al. should still be considered for future 
experiments.  
Finally, remain to be elucidated two more interesting aspects of long-lasting 
effects of MK-801: i) how NMDARs antagonism applied 24 hours before 
memory reactivation can shift processes from memory reconsolidation toward 
extinction occurrence and ii) whether this shift is long lasting. Identify a 
molecular marker or a signaling cascade specifically involved in this progression, 
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such as the increase of calcineurin in amygdala along with the shift from 
reconsolidation to extinction, as demonstrated for fear memory (Merlo et al., 
2014), could be helpful to understand if the inhibition of conditioned responding 
is certainly due to extinction occurrence. Moreover, further analysis on Zif268 
expression with Zif268 antisense oligonucleotide could be essential to understand 
whether, during sucrose instrumental memory reactivation, the expression of this 
transcription factor acts to prevent premature memory extinction or to induce 
memory reconsolidation, as suggested for fear memory by Trent et al. (2015). 
This knockout experiment could further clarify our hypothesis concerning to the 
transition from reconsolidation toward extinction. Lastly, testing for spontaneous 
recovery or memory reinstatement after sucrose re-exposure could help to 
understand if the effects of MK-801 and possibly other NMDARs antagonists 
suck as ketamine are long lasting and resistant to new exposure to unconditioned 
stimulus, such us sucrose – in our protocol – or drug of abuse, typically one of the 
main causes of relapse of addiction disorders. 
 
4.1 Conclusion 
Our findings suggest that sucrose instrumental memory reactivated with a 
short non-reinforced retrieval session can undergo reconsolidation, and this 
process can be blocked and possibly shifted to extinction occurrence with a MK-
801 metaplastic treatment 24 hours before memory reactivation.     
In conclusion, we suggest that a long-lasting metaplastic treatment with the 
NMDARs antagonist MK-801 combined 24 hours later with a short retrieval of 
sucrose instrumental memory may inhibit sucrose seeking, representing a 
potential new therapeutic intervention strategy addressing maladaptive appetitive 
memories. 
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